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ABSTRACT
In Exp. 1 ,42 calves were fed milk replacer and then starter either with or without 
1 ppm supplemental chromium (Cr) as Cr-picolinate. Neither Cr nor sex affected growth 
performance. With the exception of plasma nonesterified fatty acid concentrations (NEFA), 
weekly plasma metabolites were not affected by Cr or sex. Pre- and postfeeding plasma 
NEFA concentrations were lower in Cr-fed calves, but were not affected by sex. All calves 
seemed to become less insulin sensitive with age, as plasma glucose became lower and 
insulin higher as calves became older. During i.v. glucose tolerance tests (IVGTT), calves 
cleared glucose fester at 2 compared with 8 weeks o f age but Cr did not affect clearance at 
either week. At 2 weeks o f  age, heifers cleared glucose faster than did bulls. Plasma 
glucose increases after an i.v. propionate load were greater in heifers than in bulls but were 
not affected by Cr.
In Exp. 2 ,34 calves were fed milk replacers either without (BF) or with (HF) added 
fat and either with or without 1 ppm of dietary Cr as Cr-nicotinate. Neither Cr nor fet 
affected performance; except, weight gain was greater in HF-fed calves during the period 
calves received milk alone. Weekly plasma glucose, insulin, and triacylglycerol 
concentrations were not affected by Cr; however, plasma insulin concentrations tended to 
be lower in Cr-fed compared with control-fed calves. Weekly NEFA declined in a similar 
manner for Cr-fed and control-fed calves; however, overall, NEFA concentrations were 
greater in Cr-fed calves. Weekly cholesterol concentrations were greater in Cr, HF-fed 
calves and lower in Cr, BF-fed calves compared with controls. Added dietary Cr or fat had 
minimal effects on plasma metabolites and hormones measured after milk replacer feeding.
xi
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Using data generated by the IVGTT, a computer modeling procedure predicted that insulin 
sensitivity was increased in Cr-fed calves but reduced in HF-fed calves compared with 
controls. Overall, data suggested that Cr had little effect on metabolism or growth 
performance, but may have improved insulin sensitivity, with the most notable effects 
occurring in the initial weeks o f life.
xii
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CHAPTER I 
INTRODUCTION
The essentiality o f dietary Cr for man and many laboratory species has been 
reasonably well established (Anderson, 1987; Mertz, 1993). The most convincing evidence 
comes from long-term total parenteral nutrition studies in humans (Jeejeebhoy et al., 1977; 
Freund et al., 1979; Brown et al., 1986) and from feeding low-Cr diets to laboratory animals 
(Schroeder et al., 1963a,b; Mertz et a l, 1965a,b; Hopkins, 1965; Onkelinx, 1977; Kraszeski 
et al., 1979; Jain et al., 1981). These studies demonstrated that a Cr deficiency impairs 
glucose tolerance and that supplementation o f physiological amounts o f Cr reestablished 
normal glucose tolerance.
The only established metabolic role o f Cr is its function in the glucose tolerance 
factor (GTF), where Cr is believed to play a physiological role as a co-factor for facilitating 
insulin’s attachment to its receptors (Mertz, 1979; Offenbacher and Pi-Sunyer, 1988; Mertz, 
1993). In monogastric species, insulin has a multiplicity of effects within the body: it acts 
on a variety o f tissues including muscle, adipose, liver, and mammary, and alters a variety 
o f  processes including membrane translocases, enzyme activity, and enzyme amounts 
(Vemon and Sasaki, 1991). More specifically, insulin enhances glucose uptake by adipose 
and muscle cells, enhances amino acid uptake by muscle cells, stimulates protein synthesis, 
and inhibits protein degradation; thus, in general, insulin promotes tissue growth (Granner, 
1996). In ruminants, insulin has many similar effects, but these effects, especially on adipose 
and muscle tissue, are generally less pronounced than those observed in monogastric 
animals. The smaller response to  insulin o f  ruminants tissues have been attributed to the
1
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2pattern of feeding and the action o f the rumen, both o f which minimize the surge of 
nutrients, especially glucose, into the blood stream. Because the influx o f nutrients into the 
blood following a meal is less episodic in ruminants, there appears to be less need for tissues 
to be as acutely sensitive to insulin. In other words, the need for insulin to act rapidly to 
move nutrients into storage (i.e., glucose and amino adds into muscle and glucose and lipids 
into fat) is not as much of a priority. Nevertheless, insulin in ruminants increases on feeding 
(Bassett, 1975), and development o f diabetic-like conditions can be as severe in ruminants 
as in monogastrics (Jarrett et al., 1974). Because Cr is a component o f  the GTF-complex, 
because the GTF is important for optimum insulin effectiveness, and because insulin is 
involved in regulating a multiplidty o f metabolic events, it seems plausible that any system 
upon which insulin has an influence would work most efficiently when an animal’s Cr 
requirement is satisfied.
As alluded to above, ruminants derive small amounts o f glucose from intestinal 
absorption and the role of insulin in these animals is perhaps less well defined than in the 
nonruminant animal (Brockman, 1986). By contrast, the pre-weaned calf continues to 
absorb glucose primarily through the small intestine until its rumen begins to function as a 
result of consuming dry feed (Quigley et al., 1991). Therefore, until such time, the calf s 
absorption of nutrients is more like that o f a monogastric than that o f  an adult ruminant. 
Evidence has shown that tissue sensitivity to insulin is greater in the preruminant compared 
with the adult ruminant animal, but less than that o f the monogastric (Thiebaud et al., 1983; 
Weekes et al., 1983; Farrell et al., 1988; Metcalf and Weekes, 1990; Grutter and Blum, 
1991; Sano et al., 1991). Furthermore, irrespective o f the feeding regime employed
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3(intensively or conventionally-fed), insulin sensitivity will decrease with age. Development 
of the rumen as a result of dry feed intake however will make the calf become more insulin 
insensitive at an earlier age. Hostettler-Allen et al. (1994) showed that insulin and glucose 
concentrations in intensively-fed calves eventually become elevated to the point that there 
is the potential for urinary spillage o f blood glucose, delayed initiation o f gluconeogenic 
processes, and reduced feed efficiency. Although such exaggerated changes in insulin and 
blood glucose are less likely in conventionally-fed calves, it is possible that glycosuria, 
delayed initiation of gluconeogenic processes, and reduced feed efficiency might also exist 
in these calves. Because newborn ruminants progressively become insulin insensitive with 
age, it is conceivable that slowing the rate at which this occurs may translate into a 
metabolically more efficient animal. Improving insulin’s effectiveness may also improve 
immune modulation (i.e., enhance disease resistance) which in turn may result in greater and 
(or) more efficient rates o f gain.
Our primary hypothesis is that insulin sensitivity declines with age in conventionally 
raised dairy calves and that supplemental Cr can slow this decline. To test this hypothesis, 
two experiments were conducted to evaluate physiological (metabolic and hormonal) 
responses and performance criteria (gain, intake, efficiency) o f conventionally-fed dairy 
calves to supplemental organic Cr. Our objectives were 1) to determine if supplemental Cr 
would influence insulin sensitivity (i.e., effectiveness), as measured by changes in insulin and 
glucose concentrations following milk feedings and following intravenous infusions of 
glucose, 2) to determine if supplemental Cr would influence gluconeogenesis, as measured 
by an intravenous infusion o f propionate, 3) to determine if supplemental Cr would influence
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4circulating blood lipids and lipolysis, as measured by changes in glucose and blood lipid 
concentrations following milk feedings and following an intravenous infusion o f epinephrine, 
and 4) to determine if supplemental Cr would influence growth performance (starter intake, 
body weight gain, and feed efficiency).
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CHAPTER II 
REVIEW OF LITERATURE 
Historical Background o f Chromium
Dietary chromium (Cr) research began more than forty years ago. Until recently (5 
to 10 years ago) the majority o f  research has been conducted in humans and laboratory 
animals, as opposed to livestock. The earliest work, conducted in rats, revealed that Cr was 
required for maintaining normal glucose tolerance (Schwarz and Mertz, 1959). Since then, 
this response has been shown in humans, mice, squirrels, monkeys, and guinea pigs 
(Anderson, 1987). According to Anderson (1987), hyperinsulinemia (human, rat), 
glycosuria (human, rat), fasting hyperglycemia (human, rat, mouse), elevated serum 
cholesterol and triglycerides (human, rat, mouse), impaired growth (rat, mouse, turkey), and 
decreased longevity (rat, mouse) are among some o f the symptoms that have been attributed 
to a deficiency in Cr. In humans, the dietary need for a source o f Cr that can be used by the 
body to form the GTF-complex has been firmly established. The most convincing evidence 
for a Cr deficiency to lead to negative consequences (i.e., impaired glucose tolerance, 
requirement for exogenous insulin, peripheral neuropathy, decrease in body weight) has 
been observed in patients on long-term total parenteral nutrition (Jeejeebhoy et al., 1977; 
Freund et al., 1979; Brown et al., 1986). For example, Jeejeebhoy (1977) and co-workers 
showed that addition o f 250 /j.g/d o f Cr (as CrCl3) into infusion solutions for two wk 
returned glucose tolerance to normal, peripheral neuropathy disappeared, body weight (BW) 
returned to normal, and exogenous insulin was no longer needed.
5
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
6Currently, the only established Cr recommendation set forth by the National 
Research Council (NRC) has been for lactating, gestating, or growing laboratory rats (0.3 
ppm; NRC, 1995). Based on estimates o f the Cr content of typical diets the NRC suggests 
a safe and adequate level o f 2 ppm for the mouse, and an allowance o f 0.6 ppm for the 
guinea pig (NRC, 1995). In adult humans, an intake of 50to 200 //g/d is recommended as 
a safe and adequate level (NRC, 1989a). For poultry, the NRC does not suggest a Cr 
requirement (NRC, 1994) however, based on available data it has been suggested that Cr
will eventually be recommended at 3 ppm (Puls, 1990).
Among commercial livestock, the FDA only allows supplemental Cr to be added to
swine diets. In contrast, Cr supplementation to livestock diets, in most foreign countries, 
is allowed. The NRC currently does not provide any recommended Cr level for livestock 
diets but does recognize that some source o f Cr that can be incorporated in the GTF is 
needed (NRC, 1988a,b; NRC, 1989a,b; NRC, 1994; NRC, 1995; NRC, 1996). As data 
continue to emerge regarding Cr essentiality in livestock diets, there will be increasing 
pressure to approve the use of Cr in mineral supplements. Recently, the NRC (1997) 
published a book entitled The Role o f  Chromium in Animal Nutrition that covers the 
majority o f Cr research that has been conducted in livestock animals. Although some data 
supports improved performance, many o f  the proposed benefits are less obvious, such as 
improved immune response, enhanced reproduction, improved recovery from stress and (or) 
resistance to disease, and decreased incidences of metabolic disorders. Because 
supplemental Cr appears to act more as a nutrient than as a pharmacological agent, it is 
believed that any beneficial effects may be limited to situations where an animal is clearly or
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
7at least marginally deficient in Cr (Anderson, 1986). Progress toward establishing Cr 
requirements for livestock has been slow and undoubtedly will continue to be slow until 
simple, inexpensive methods become available to evaluate the bioavailability (i.e., absorption 
and retention) and biological activity (i.e., ability to potentiate insulin) o f  Cr in feeds and 
supplements. Although a variety o f Cr supplements (Cr-nicotinate, CrCl3 Cr-picolinate, 
chelated Cr, and high-Cr-yeast, among others) have been included in livestock diets, 
relatively few comparative studies, especially in ruminants, have been conducted. The lack 
o f  comparative studies also appears to be a factor that has hindered the progress toward 
establishing Cr requirements for livestock.
Biologically Active Forms of Chromium
Chromium exists in oxidation states varying from -2 to +6 (Mertz, 1969). 
However, its most stable state and the state most likely to persist and have metabolic activity 
in biological systems, is the trivalent or +3 state (Mertz, 1969; Borel and Anderson, 1984; 
Wallach, 1985; Kumpulainen, 1988; Ducros, 1992). As previously mentioned, it is the 
GTF-complex, o f  which trivalent Cr is an active component, that possesses biological 
activity. The exact structure of the GTF is not known; however, it appears to be composed 
o f  Cr, nicotinic acid, and the amino acids glycine, cysteine, and glutamic acid (Mertz et al., 
1978; Toepfer et al., 1977). The mechanism(s) by which biologically active Cr improves 
glucose tolerance and (or) insulin effectiveness is not fully understood. However, proposed 
theories include more efficient binding o f insulin to its receptors (Mertz and Roginski, 1963; 
Mertz, 1969; Anderson, 1987), increased production or membrane insertion rates o f insulin
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8receptors (Anderson, 1986; Evans and Bowman, 1992), or possibly, a combination o f the 
two mechanisms (Anderson, 1987).
Similar mechanistic alterations have been used to explain the onset o f reduced insulin 
sensitivity in humans consuming diets high in fat (Kolterman et al., 1980; Marangou et al., 
1986; Bonadonna et al., 1990). Because insulin insensitivity, at least in humans and some 
laboratory animals, can develop rapidly in response to the level o f dietary fat consumed (i.e., 
within d depending on the percentage o f energy in the diet coming from fat), it has been 
suggested that the change (i.e., reduced insulin sensitivity) may primarily be a response to 
fat intake, and that obesity only exaggerates the effect (Harris and Kor, 1992). This further 
suggests that tissue sensitivity to insulin is in all likelihood maintained/regulated by both 
acute (i.e., binding capacity o f insulin receptors) and longer term (post-receptor) 
mechanistic changes at the cellular level.
Supplementation o f both organic and inorganic trivalent Cr have been shown to elicit 
biological responses; although, the degree to which, and the time required before, 
observable biological responses are elicited, seem to vary. An understanding of why these 
differences occur is not readily apparent, but it is known that bioavailability (i.e., absorption 
and retention) and biological activity (i.e., ability to potentiate insulin) varies among the Cr 
compounds that have been included in diets to increase Cr intake. In processed feeds and 
foods the Cr that exists is not well understood; however, it is thought that most o f  this Cr 
is in a form that provides little, if any, Cr to the glucose tolerance factor complex. Inorganic 
sources o f Cr are also thought to provide little, if any, benefit as a source o f Cr for the GTF 
complex (Mertz et al., 1965; Anderson et al., 1983; Anderson and Kozlovsky, 1985;
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9Anderson, 1988) until converted to an organic form, but where or how this may occur is 
unclear (Borel and Anderson, 1984).
The absorption of inorganic Cr has been estimated to be between 0.4% and 3% 
(Dowling et al., 1989), similar to that which has been reported for Cr found inherently in 
feed (0.5 and 2.0%; Anderson and Kozlovsky, 1985). Organic synthetic Cr is thought to 
be absorbed three to fourfold more effectively than inorganic Cr (Evans, 1989b; Mertz, 
1976), but may still be less than the 10 to 25% estimated absorption from the organic form 
found in Brewer’s yeast (Mertz, 1976). More recently, humans given 400 fig Cr as Cr 
picolinate/d were estimated to have absorbed only 2.5% o f the Cr (Gargas et al., 1994). 
Current thinking is that only organic trivalent Cr will be incorporated into the GTF complex. 
In addition to the previously mentioned factors that have hindered estimating Cr 
requirements, Cr analysis is technically demanding and requires specialized instruments 
capable o f making sophisticated background corrections. Furthermore, questions persist 
as to whether the total Cr content o f a diet bears much, if any, relationship to its biological 
activity (Vobecky et al., 1979).
Effect o f Chromium on Carbohydrate Metabolism
Impaired glucose tolerance (i.e., when glucose is cleared from the blood at a slower 
rate) is the classical metabolic observation resulting from a Cr deficiency (Wallach, 1985; 
Mertz, 1993). Although the mechanistic effect(s) o f  Cr, or more accurately the Cr-GTF- 
complex, at the cellular level (i.e., receptor) still need to be clarified, it appears that impaired 
(i.e., decreased) insulin responsiveness (i.e., effectiveness) may be the fundamental 
biological malfunction, and that all other symptoms that manifest themselves are a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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consequence of this malfunction. In support of this, studies with epididymal fat tissue taken 
from Cr-sufficient and Cr-deficient rats showed that exogenous insulin only increased 
glucose uptake in tissues taken from Cr-sufficient rats (Mertz, et al., 1961; Mertz and 
Roginski, 1971; Mertz, 1981). Tissue samples from the Cr-sufficient rats were also able to 
convert more glucose to glycogen (Roginski and Mertz, 1969). In vitro, the addition of 
glucose and insulin failed to increase 51Cr binding to  tissues (brain, kidney, liver) in which 
glucose uptake is independent o f insulin, but in insulin sensitive tissues (muscle, adipose) 
glucose and insulin increased 51Cr binding (Morris et al., 1993). In hypoglycemic patients 
receiving supplemental Cr, insulin binding and insulin receptor numbers on red blood cells 
were observed to have increased (Anderson et al., 1987). Likewise, Berrio et al. (1995) 
showed that red blood cell ghosts and isolated adipocytes obtained from pigs fed diets 
containing Cr had a greater ability to bind insulin.
In humans and laboratory animals, ingestion o f high (> 40% of energy) and moderate 
(> 30% of energy) fat diets has been shown to reduce insulin sensitivity within d or wk, 
respectively (Storlein et al., 1986; Sidery et al., 1990). Studies of this nature (i.e., added 
fat) have been interpreted to suggest that both immediate (i.e., binding to receptors) and 
longer term (i.e., post-receptor) mechanistic alterations are probably involved in regulating 
insulin sensitivity (Harris and Kor, 1992). Supplementation o f Cr (as CrCI3) to humans 
considered to be hyperglycemic and hypoglycemic resulted in lower and greater glucose 
concentrations, respectively, at 90 min following a glucose challenge (Anderson et al., 
1983). These findings suggest that Cr is probably involved in more than just increasing 
insulin’s binding capacity to its receptors and that post-receptor changes are also occurring.
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Further evidence that the mechanistic effects o f  Cr (i.e., GTF) are mediated through insulin 
action is strengthened by the observation that supplementing Cr, in the absence o f insulin, 
did not increase glucose uptake by insulin sensitive tissues (Anderson, 1987).
Human and Laboratory Animal Studies. In overt-diabetic individuals displaying 
abnormal glucose tolerance following an oral glucose tolerance test, supplemental Cr was 
found to increase glucose clearance (Liu and Morris, 1978; Grant and McMullen, 1982; 
Polansky et al., 1982). Similarly, Elias et al. (1984) showed that giving supplemental Cr to 
Type-II diabetics increased insulin sensitivity in these subjects and reduced their dependence 
for exogenous insulin. Mildly-hyperglycemic individuals consuming diets low in Cr were 
observed to display low glucose tolerance; however, once subjects began receiving 
supplemental Cr, glucose tolerance returned to normal (Anderson et al., 1991). In this study 
circulating insulin concentrations also returned toward more physiological normal levels. 
In elderly volunteers fed a Cr-rich Brewer’s yeast as opposed to a Cr-deficient Torula yeast 
Offenbacher and Pi-Sunyer (1980) observed that the volunteers fed the Cr-rich yeast had 
greater glucose tolerance and lower plasma insulin levels. Administration o f supplemental 
Cr orally, intravenously, and via a stomach tube to rats has also been shown to lower fasting 
glucose concentrations and increase glucose clearance (Mertz, 1974b; Mertz, 1976; Evans, 
1989a; Evans, 1991; Evans and Pouchnik, 1993). Although both, organic and inorganic 
forms of Cr have been shown to decrease fasting serum glucose concentrations, Vinson and 
Hsiao (1985) reported greater decrease’s following supplementation o f organic Cr.
Livestock Studies. After an early study showed that a synthetic, Cr-containing GTF 
substance was biologically active in pigs (Steele et al., 1977) there was a lag o f 10 to 13
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years before studies were again initiated. Since then a plethora of studies have been 
conducted to evaluate different Cr compounds and to establish Cr requirements. The 
majority o f studies however have been designed to investigate whether growth performance 
or carcass criteria were affected, and not necessarily whether glucose homeostasis or insulin 
action were influenced. Nonetheless, some studies have provided evidence to suggest that 
supplementing diets with Cr may improve insulin action in pigs (Evock-Clover et al., 1993; 
Lindemann et al., 1995; Amoikon et al., 1995). Berrio et al. (1995) also showed that 
binding o f insulin to red blood ghosts cells and isolated adipocytes was greater in samples 
taken from Cr-fed compared with control-fed pigs. By contrast, Ward et al. (1994) found 
less binding o f insulin to liver cell membranes in samples taken from Cr-fed compared with 
control-fed pigs.
Ruminants use volatile fatty acids rather than glucose as their major energy source 
and their response to insulin is perhaps less well defined than that of monogastric animals. 
Insulin seems to have less anabolic effect on ruminant muscle and adipose tissues (Vernon 
and Sasaki, 1991; Lobley, 1993) and glucose uptake by the mammary cells appears to be 
independent o f the action o f  insulin (Brockman, 1986; Vernon and Sasaki, 1991). 
Superficially, there seems little reason to anticipate that supplemental Cr would be of benefit 
to the ruminant. Nonetheless, impaired insulin effectiveness (i.e., non-insulin diabetic-like 
state) can be as severe in ruminants as in nonruminant species (Jarrett et al., 1974; Vernon 
and Sasaki, 1991). Insulin resistance induced in lactating cows by feeding of supplemental 
fat has also beat shown to impair amino acid transport into the mammary gland (Palmquist 
and Moser, 1981). Although insulin has similar metabolic effects in nonruminant and
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ruminant animals, its effects on insulin-dependent tissues in ruminants are generally less 
apparent (Vernon and Sasaki, 1991). It seems plausible that supplementing Cr in the diets 
fed to ruminants should produce metabolic changes similar to those that have been observed 
in nonruminants.
In ruminants, the majority o f Cr-supplementation studies have been conducted with 
“market-transit” stressed feeder calves (Chang and Mowat, 1992; Mowat et al., 1993; 
Chang et al., 1995; Kegley and Spears, 1995; Kegley et al., 1997b). In these studies, Cr 
sources (high-Cr yeast, CrCl3, chelated Cr), supplementation levels (ranged from 0.4 to 1 
ppm), and the d on which blood variables were measured differed from study to  study. 
Therefore, some confounding factors may exist in summarizing these studies together. 
Nonetheless these studies all began Cr supplementation following the calves’ arrival at the 
experimental site (i.e., after transit) and, overall, found a slight tendency (not always 
significant) for Cr-fed calves to have lower prefeeding glucose concentrations during the 
first month after arrival; however, over time, this effect gradually diminished. In the study 
conducted by Kegley and Spears (1995) postfeeding (2 h) glucose concentrations were not 
affected by supplemental Cr (as CrCl3, high-Cr yeast, or Cr nicotinic acid complex). 
However, during an IVGTT (wk 9 o f Cr supplementation) the steers receiving the Cr 
nicotinic acid complex tended to clear glucose faster than steers receiving the other Cr 
sources, but clearance rates between any one o f the individual groups of Cr-fed steers did 
not differ from the group o f control-fed steers.
When Cr, as Cr picolinate, was supplemented for 8 wk, in a com-cottonseed hull 
basal diet fed to Holstein calves (steers and heifers) considered physiologically adapted, no
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differences in prefeeding glucose or insulin concentrations were observed between the Cr- 
fed and the control-fed calves (Bunting et al., 1994). However, during an IVGTT the Cr- 
fed steers and heifers cleared glucose fester (40 and 27%, respectively). In addition, during 
an IVICT, the Cr-fed heifers cleared glucose fester (44% fester than control-fed heifers) and 
the Cr-fed steers tended to clear glucose faster (27% faster than control-fed bulls). The 
faster glucose clearance rates were interpreted to suggest that Cr had increased the 
sensitivity o f these calves’ tissues to insulin. In weaned lambs, prefeeding glucose and 
insulin concentrations were also not affected when supplemental Cr picolinate was fed 
(Fomea et al., 1994; Kitchalong et al., 1995; DePew et al., 1996; Forbes et al., 1998). 
Kitchaiong et al. (1995) and Forbes et al. (1998) also did not observe any differences when 
the glucose clearance rates obtained from the IVGTT and IVICT were compared between 
Cr-fed and control-fed lambs. However, Kitchalong et al. (1995) did observe that Cr-fed 
lambs had lower glucose and greater insulin concentrations in response to the IVICT 
conducted 2 wk after supplementation was begun compared with what was observed after 
10 vie of Cr supplementation. In growing lambs, Samsell and Spears (1989) reported that 
prefeeding plasma glucose and insulin concentrations were also not affected by supplemental 
Cr, as CrCl3 However, they did note that Cr supplementation lowered fasting (48 h) plasma 
glucose concentrations in lambs fed the low-fiber diet.
Kegley and Spears (1997a) conducted an experiment to determine if Cr 
supplementation would affect glucose metabolism and (or) insulin effectiveness in milk-fed 
Holstein bull calves. Calves were obtained from a local dairy at approximately 1 wk o f age 
and fed a commercial milk replacer without or with supplemental Cr (.4 ppm) as either CrCl3
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or a Cr nicotinic acid complex throughout the next 9 to 10 wk of life. Glucose 
concentrations before and after feeding (1 h) were not different between Cr-fed and control- 
fed calves on any of the individual sampling d. Because glucose concentrations increased 
with age the authors speculated that the rise was a reflection o f  increased dietary lactose 
intakes as milk intake was adjusted to weight gain, or was a reflection of increased insulin 
resistance.
Effect o f Chromium on Lipid Metabolism
Perhaps the most consistently observed metabolic effects to supplemental Cr have 
been changes in blood lipid concentrations. Most notably, supplemental Cr has been 
reported to lower circulating cholesterol and NEFA concentrations in humans and 
Iaboratoiy animals (Doisy et al., 1976; Liu and Morris, 1978; Anderson et al., 1988; Mertz, 
1993), pigs (Page et al., 1993), as well as in ruminants (Samsell and Spears, 1989; Bunting 
et al., 1994; Kitchalong et al., 1995; Yang et al., 1996).
Human and Laboratory Animal Studies. In middle-aged men, Wang et al. (1989) 
reported that individuals fed the CrCl3 or Cr-rich Brewer’s yeast had lower total cholesterol 
and low density lipoprotein cholesterol concentrations compared with individual fed a 
placebo. Similarly, Offenbacher and Pi-Sunyer (1980) reported that elderly-individuals fed 
a Cr-rich Brewer’s yeast had lower plasma cholesterol and total lipids when compared with 
individuals fed a Cr-deficient Torula yeast for 8 wk. Chromium supplementation has also 
been reported to reduce total cholesterol, low density lipoprotein cholesterol, and 
triacylglycerol concentrations, and increase high density lipoprotein concentrations in 
humans considered to be mildly hypercholesteremic (Press et al., 1990; Abraham et al.,
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1992). In addition, Cr supplementation of various Cr sources has been reported to result 
in similar reductions in cholesterol levels in healthy individuals and weight-training athletes 
(Press et al., 1990; Lefavi et al., 1993). In rats fed hypercholesterolemic diets, Cr 
supplementation has been reported to decrease total cholesterol concentrations (Staub et 
al., 1969). O’Flaherty and McCarty (1978) also reported that Cr-fed rats released less 
NEFA from adipose tissues compared with control-fed rats. In various laboratory animals, 
decreases in total hepatic lipid content and decreased occurrences o f aortic plaques have 
been observed following Cr supplementation to animals fed both typical and high-cholesterol 
diets (Abraham et al., 1980; Abraham et al., 1982a,b; Schroeder and Balassa, 1985; Li and 
Stoecker, 1986).
Livestock Studies. Page et al. (1993) reported that total cholesterol concentrations 
were lower in pigs fed Cr picolinate than in control-fed pigs. By contrast, Evock-Clover et 
al. (1993) and Amoikon et al. (1995) reported that total cholesterol concentrations were 
greater in pigs fed Cr picolinate than in control-fed pigs. In addition, Evock-Clover et al. 
(1993) also reported that high-density lipoprotein cholesterol concentrations were increased 
in Cr-fed compared with control-fed pigs. Kitchalong et al. (1995) reported that lambs fed 
Cr picolinate had lower cholesterol concentrations compared with control-fed lambs after 
2 wk on the experimental diet; however, this effect was no longer apparent during the 7th 
or 11th wk o f the trial. Forbes et al. (1998) also observed that supplemental Cr did not 
affect cholesterol concentrations in lambs. Kegley et al. (1997a) reported that milk-fed 
Holstein bulls receiving supplemental Cr, as CrCl3 or a Cr-nicotinic acid compound, had 
similar postfeeding (3 h) cholesterol concentrations throughout the 9 to 10 wk study when
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compared with control-fed bulls. Holstein steers and heifers fed com-cottonseed hull based 
diets supplemented with Cr-picolinate had lower total plasma cholesterol concentrations at 
some individual sampling times (wk 4 and 6 for steers and calves, respectively) but overall 
no difference was observed (Bunting et al., 1994). In Holstein steers and heifers, Bunting 
et al. (1994) reported no effect o f supplemental Cr picolinate on NEFA concentrations; by 
contrast, in yearling ewes (Forbes et al., 1998) and weaned lambs (Kitchalong et al., 1995) 
addition o f Cr picolinate to basal diets lowered NEFA concentrations. The mechanism of 
action o f Cr on lipid metabolism is not understood. However, Mertz (1993) suggested that 
the more dramatic hypolipidemic effects o f  organic Cr in humans may be attributable simply 
to increased glucose tolerance with corresponding reductions in lipolysis. Samsell and 
Spears (1989) hypothesized that the effects o f Cr on lipogenesis were probably being 
influenced through the actions o f insulin.
Chromium and the Neonate
Information regarding Cr nutrition before weaning is basically limited to determining 
the Cr content of neonatal food sources (i.e., breast milk, infant formula, etc.) and 
epidemiological comparisons o f Cr status among different population groups by measuring 
Cr content in urine, tissue, and hair samples. From studies that have measured the Cr status 
o f  pre- and full-term infants and infants from diabetic and non-diabetic mothers, it has been 
determined that the Cr content of newborns is two and one-half times that o f  their mothers. 
The fetus concentrates Cr in-utero, and the Cr status of the newborn has a correlation to 
that o f  the mother’s Cr nutritional state (Hambidge and Baum, 1971; Saner and Gurson, 
1976; Friel et al., 1985). It has also been observed that urinary Cr concentrations increase
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significantly by the 3rd d postnatally (Saner and Gurson, 1976; Saner, 1979) and that tissue 
Cr levels decline in later infancy (Hambidge and Baum, 1971). Although the relative 
importance o f dietary Cr throughout the postnatal period is uncertain (Friel et al., 1985), Cr 
metabolism is evidently initiated early in life. The best support for this seems to come from 
studies with malnourished infants, where it has been observed that Cr supplementation 
improves glucose tolerance (Hopkins et al., 1968; Gurson and Saner, 1971).
The American Academy o f  Pediatrics recommends that breast milk be the sole 
source of nutrients for infants until about 4-6 mo o f age (American Academy of Pediatrics, 
1976). Friel et al. (1985) reported that the major source o f Cr for infants comes from milk 
sources; however, milk, particularly artificial milk formulas, reportedly contain low 
concentrations o f  Cr (Hambidge, 1974). Other studies report that the Cr content of 
commercial milk formulas is greater than that o f human breast milk (Vobecky et al., 1979; 
Kumpulainen and Vuori, 1980; Casey and Hambidge, 1984). Whichever the case, the Cr 
obtained from milk sources is considered small. As with most Cr measurements, the 
concentration of Cr measured in human breast milk has decreased over the past thirty years; 
ranging from a high of 50.5 ng/mL in 1966 to a low of 0.18 ng/mL in 1992 (Anderson et 
al., 1993). Similarly, the Cr content o f  cows’ milk is also considered small and probably 
provides less than 0.5 ng/mL (Anderson et al., 1992). Improvements in methods o f analysis 
and an increased awareness of Cr contamination during all phases o f collection and analysis 
have led to increasingly accurate values for Cr in tissues and body fluids over the past 
decade. The older values for Cr, in hair, however, appear to still be reliable because hair
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contains 200- to 1000-fold higher levels o f Cr compared with those contained in tissue and 
body fluid samples (Anderson et al., 1993).
Anderson et al. (1993) reported that by d 60 postpartum the Cr concentration of 
human breast milk was 0.18 ng/mL. At this concentration, when breast milk is the sole 
source of Cr intake, an infant would need to consume 55.6 L in order to obtain the minimum 
suggested Cr intake o f 10 //g/d. Realistically, at a typical daily breast milk intake o f 715 
mL/d by d 60 postpartum (Borschel et al., 1986) an infant would receive less than 2% o f the 
minimum estimated safe and adequate daily intake for infants less than 6 months o f age 
(Anderson et al., 1993).
An adequate dietary intake o f  Cr appears to be of particular concern for pregnant 
and lactadng females, because during these states there is an increased burden placed on Cr 
stores (Hambidge and Baum, 1971; Mahalko and Bennion, 1976). By using hair Cr 
concentrations as a reflection of Cr status, it has been determined that Cr concentrations are 
greater in primiparous than multiparous women (Hambidge and Rodgerson, 1969; Mahalko 
and Beenion, 1976). Mahalko and Bennion (1976) further observed that it takes more than 
four years between pregnancies before hair Cr concentrations return to pre-pregnancy levels. 
Thus it follows that an infant born within four years of its sibling would have a greater 
likelihood o f being Cr deficient. Extrapolation of these findings to newborn ruminants 
would suggest that, with each successive lactation, the amount o f Cr that the newborn 
would obtain from its dam would decrease. Research in this area is needed to determine 
whether Cr supplementation to the dam, and subsequently to the calf, would be beneficial.
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Friel and co-workers (1985) conducted a study o f 103 infants and found that at three 
mo of age 23% of pre-term babies and 35% of full-term babies failed to meet the minimum 
recommended safe and adequate daily Cr intake. As already mentioned, marginal dietary 
intakes of Cr have been related to impaired glucose tolerance in some human population 
groups. Friel and co-workers (1985) suggested that' abnormalities in carbohydrate 
metabolism, not infrequent in early post-natal life, may be related to sub-optimal Cr status.
Saner et al. (1980) conducted a study with newborn infants in which an intravenous 
glucose tolerance test was performed before 24 h o f  age, then gave Cr (250 fj.g CrCl3 in 2 
ml of tea), and then repeated the test approximately 13 h after the administration of Cr. An 
average glucose clearance rate o f 1.22% per min was observed (1.34 and .90% per min for 
the Cr-supplemented and control group, respectively) among the infants when they were less 
than 24 h old and an average clearance rate o f 2.67% per min was observed (2.58 and 
2.04% per min for the Cr-supplemented and control group, respectively) among the infants 
when they were about 37 h old. A significant increase in glucose clearance was observed 
on the 2nd d o f  life in both groups o f newborns. These authors concluded that the low 
glucose clearance rate in the newborn, irrespective o f administered Cr, may be taken as 
evidence that the active role o f  Cr may be inadequate in the newborn. The lack of precise 
control of glucose homeostasis in the human neonate has been postulated to be a secondary 
consequence of either a decreased sensitivity to or a decreased resistance to insulin (Cowett 
et al., 1983).
In adult monogastric animals, blood glucose and plasma insulin generally increase 
following oral or intravenous glucose tolerance tests. In response to an influx o f glucose
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into the blood stream, the body responds by inhibiting hepatic glucose production and 
increasing the rate at which glucose is taken up by tissues, thereby avoiding the development 
o f hyperglycemia (Unger, 1981). Regulation o f glucose homoeostasis in newborns 
however, may be less well developed, since evidence has shown that hepatic glucose 
production is not normally suppressed following intravenous glucose tolerance tests in 
infants (Cowett et al., 1983), dogs (Varma et al., 1973), and rats (Ferre et al., 1985; Issad 
et al., 1987). Studies that have employed intravenous glucose tolerance tests to measure 
glucose homeostasis in newborn infants (<48 h) have shown that low glucose clearance rates 
characterize the 1st few d of life (Baird and Farquhar, 1962; Bowie et al., 1963; Falorai et 
al., 1974). A delay in pancreatic insulin release has been suggested as a primary reason for 
the slowed rate o f glucose clearance (Saner et al., 1980). Insulin insensitivity appears to be 
a common characteristic of newborns; however, the persistency o f  this insulin insensitivity 
also appears to vary among species. In human newborns, insulin sensitivity increases within 
the 1st wk o f life (Baird and Farquhar, 1962; Bowie et al., 1963; Falomi et al., 1974), in rats 
between the 2nd and 4th wk of life (Issad et al., 1987), and in dogs between the 7th and 8th 
wk o f life (Varma et al., 1973). Although, the mechanism(s) responsible for these changes 
are unclear, it appears that a nutritional component may exist. For example, in the rat 
experiment, an increase in insulin sensitivity coincided with the time that the pups were 
weaned from a high-fat, low-carbohydrate diet (milk) to a high-carbohydrate, low-fat diet 
(laboratory weaning diet; Issad et al., 1987). In this study, it was suggested that changes 
in insulin sensitivity (in this case an increase) may be, to  a degree, influenced by nutrition 
(i.e., high fat vs. high carbohydrate diet) but that there was also a possible influence of
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developmental state. Whether changes in insulin sensitivity are due to nutrition, stage of 
development (i.e., age), or a combination o f the two, in the aforementioned monogastric 
species, insulin sensitivity increases during the neonatal period.
Following consumption o f a meal, glucose is absorbed from the intestine similarly 
in young ruminant (pre-weaned) and monogastric animals. Subsequently, glucose and 
shortly thereafter insulin concentrations rise in the blood. However, as far as glucose 
utilization is concerned, the tissues o f  the young monogastric have a greater response to 
insulin, as they can convert glucose to fatty acid at a high rate (this process provides a sink 
for glucose disposal), whereas in the ruminant this capacity is very limited (Vernon and 
Sasaki, 1991). In addition, the capacity to transport glucose across the plasma membrane 
o f adipocytes is less in ruminants compared with nonruminants. Since, postprandial insulin 
and glucose concentrations in intensively-fed calves have been suggested to become elevated 
to the point that urinary spillage of blood glucose is possible (Hostettler-Allen et al., 1994). 
It would seem that if the tissues of intensively-fed calves could be made more responsive to 
insulin, glucose might potentially be used more efficiently.
To investigate this question, Kegley et al. (1997a) conducted a study with milk-fed 
dairy calves from 1 to 10 wk o f age to determine if  the insulin potentiating action of Cr 
would increase or at least maintain insulin sensitivity as the calves became older. Chromium 
was supplemented in a commercial milk replacer at 0.4 ppm as either CrCl3 or a Cr-nicotinic 
acid complex. Chromium did not affect growth performance, urea-N, glucose before or 
after (1 h) feeding, and cholesterol (3 h after feeding) on any of the sampling d. Chromium 
also did not affect glucose and insulin response patterns or glucose clearance rates in
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response to an IVGTT or following consumption of milk replacer. However, based on the 
glucose and insulin changes observed following an insulin injection, these authors concluded 
that the tissues in the Cr-fed calves might have been more sensitive to insulin. Other 
observations from this experiment, but reported in a separate paper (Kegley et al., 1996) 
discussed the effects that supplemental Cr had on the immune system. Although most 
responses were minimal, the calves fed the Cr-nicotinic acid complex supplemented-replacer 
were observed to have a greater inflammatory response to an intradermal injection of 
phytohemagglutinin injection than the control-replacer-fed calves. Serum cortisol 
concentrations following a challenge with an infectious bovine rhinotracheitis virus were 
also lower in Cr-fed compared with control-fed calves. From this study, these authors 
concluded that addition o f Cr to milk replacer may enhance immunity and, thus, increase 
disease resistance in young calves.
The only other study conducted with ruminants in which the animals might be able 
to be classified as neonates was conducted by Arthington et al. (1997). In this study, 3 mg 
Cr/d of a high-Cr-yeast product was supplemented to a calf starter and fed to weaned (6 to 
8 wk old) Holstein bull calves over the next S3 d. Supplemental Cr did not affect ADG or 
rectal temperatures. On d 53 of the trial, calves were inoculated with bovine herpesvirus-1 
and 24 h later blood and urine samples and rectal temperatures were collected at 6-h 
intervals over the next 6 d. Cortisol, ACTH, plasma tumor necrosis factor-a, rectal 
temperatures, and trace mineral excreted in the urine were not affected by Cr. These 
authors concluded that Cr supplementation using high-Cr-yeast did not alter stress responses 
o f young, weaned calves experimentally inoculated with bovine herpesvirus-1.
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Implications o f Chromium During Stress
Stress, in general, is the body’s response to a threat or demand (i.e., some stimuli) 
arising from a new or changing situation where the bodies’ reaction to that stimulus disturbs 
its normal physiological equilibrium and (or) homeostasis (Hadley, 1988; Guyton, 1991). 
Two stages o f stress exist. During the initial stage, the alarm phase, the body mobilizes its 
fight or flight defenses, either to resist the stress-causing factor or to adapt to it. In this 
stage, the pituitary-adrenocortical system pours hormones into the bloodstream. The pulse 
quickens, the lungs take in more oxygen to fuel the muscles, blood sugar increases to supply 
added energy, and digestion slows. In stage two, the resistance stage, the body begins to 
repair the incidental damage caused during the alarm stage. If the stressful situation is 
resolved, the symptoms brought on by the stress will gradually subside. However, if  the 
stressful situation is not resolved vital organs can become affected which in turn may lead 
to an increased risk of disease or even death (Hadley, 1988; Guyton, 1991).
The initial hormonal response to stress is the release o f epinephrine and 
norepinephrine. Although these hormones cause short-lived effects, only 20 to 30 s, they 
increase gluconeogenesis and glycogenolysis in the liver and skeletal muscle, increase 
lipolytic activity, and increase general metabolism (Hadley, 1988; Guyton, 1991). A variety 
o f  nonspecific stimuli can cause marked increases in the rate o f cortisol secretion by the 
adrenal cortex (Hadley et al., 1988; Guyton, 1991). Cortisol, a glucocorticoid, promotes 
gluconeogenesis but reduces glucose utilization (Guyton, 1991). The increased rate o f 
gluconeogenesis coupled with a reduction in the rate of glucose uptake by cells causes blood 
glucose concentrations to rise. Although cortisol provides a positive benefit by suppressing
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the inflammatory response in the short-term (Guyton, 1991), elevated levels over prolonged 
periods can impair immune response, such that relatively innocuous infections can escalate 
to  the point o f extreme morbidity (Goodman, 1988). During prolonged stress, fuels that 
could be used to promote growth are no longer available, because they must now be used 
to  fight off an infection or repair damaged tissue.
Evidence from studies with humans and mice suggest that various physiological or 
metabolic challenges (i.e., elevated intakes o f glucose, low protein diets, infection, strenuous 
exercise, trauma) increase urinary excretion o f Cr (Pekarek et al., 1975; Borel et al., 1984; 
Anderson et al., 1988). These findings have led some investigators to suggest that animals 
must be under some form of stress before a beneficial response from Cr supplementation will 
be observed (Anderson, 1994b; Mowat, 1994). In livestock, stress has been clearly shown 
to  lead to reduced performance (Khansari et al., 1990).
Urinary Cr levels are recognized as an indicator o f Cr mobilization, because they 
increase with the intensity and duration o f the stress (Anderson et al., 1990). The IVGTT 
is the most commonly used diagnostic technique to measure the effects of Cr 
supplementation on insulin effectiveness. Although glucose loading increases Cr 
mobilization, as demonstrated by greater urinary Cr excretion, it is not nearly as great as 
what is observed following physical trauma or strenuous exercise. Therefore, the amount 
o f  Cr lost in the urine may be dependent on or be an indication o f the degree o f stress 
imposed (Anderson, 1994b).
Studies involving Cr supplementation to livestock that are under significant stress 
are limited. Researchers have reported that stressed feeder calves (stress was transportation
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to a new facility) that received supplemental Cr had improved performance, reduced 
morbidity, and improved humoral immune function (Chang and Mowat, 1992; Moonsie- 
Shageer and Mowat, 1993; Mowat et al., 1993; Wright et al., 1994; Kegley and Spears, 
1995). In contrast, when non-stressed feeder calves were studied over longer feeding 
periods, growth performance was not influenced by Cr supplementation (Chang and Mowat, 
1992; Chang et al., 1995; Bunting et al., 1994, Mathison and Engstrom, 1995).
Some studies with stressed cattle have reported a decrease in serum cortisol 
concentrations in Cr supplemented animals (Chang and Mowat, 1992; Moonsie-Shageer and 
Mowat, 1993). Supplementation with 0, .2, .5, and 1 ppm Cr from a high-Cr yeast to 
transit-stressed feeder calves resulted in a linear decrease in serum cortisol concentrations 
during the 1st 28 d o f the experiment (Moonsie-Shageer and Mowat, 1993). Chang and 
Mowat (1992) also reported that high-Cr yeast decreased serum cortisol concentrations in 
transit-stressed steers after 64 d o f supplementation. By contrast supplementation o f  a high- 
Cr yeast product to younger (6 to 8 wk old) weaned calves did not afreet cortisol 
concentrations.
Physical, nutritional, and emotional stress are all possibilities in the neonatal calf. 
Situations that may lead to chronic stress and consequently to elevated cortisol levels in the 
young calf could include extremes in temperature (hot to cold), nutrition (transition from 
liquid to dry fed diet), disease, surgery, restraint and almost any type o f trauma. Cortisol 
decreases immune system functions (Kelley, 1988; Muneer et al., 1988).
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Implications o f Chromium on Immune Function
In laboratory animals, supplemental Cr has been shown to increase resistance to 
pulmonary infections (Schroeder et al., 1964) and decrease mortality rates associated with 
experimentally induced acute hemorrhages (Mertz and Roginski, 1969). In feedlot cattle 
supplemental Cr was shown to reduce haptoglobin (an acute phase protein that increases 
during trauma or inflamation) concentrations (Wright et al., 1995) and increase humoral 
immune response and reduce morbidity (Change and Mowat, 1992; Moonsie-Shageer and 
Mowat, 1993; Mowat et al., 1993; Wright et al., 1995). In newly arrived transit-stressed 
calves, supplemental Cr reduced the incidence o f bovine respiratory disease (Mowat et al., 
1993; Lindell et al., 1994). Supplemental Cr has also been reported to decrease morbidity 
(and) or reduce the number o f relapses in newly arrived feeder steers in some studies 
(Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993; Wright et al., 1994), but not 
other studies (Chang and Mowat, 1992; Chang et al., 1995).
Dairy cows fed supplemental Cr during the periparturient period (6 wk pre to 16 wk 
postpartum) had increased in vitro concanavalin A stimulated lymphocyte blastogenic 
responses and prevented a decrease in blastogenic response that were observed in controls 
at two wk prepartum (Burton et al., 1994). Chromium supplementation with high-Cr yeast 
did not alter the stress responses of calves experimentally inoculated with bovine 
herpesvirus-1 (Arthington et al., 1997).
Kegley et al. (1996) reported that a greater inflammatory response to intradermal 
phytohemagglutinin (used to evaluate cell-mediated immune response) was observed in 
milk-fed calves receiving supplemental Cr as either a Cr-nicotinic acid complex or CrCl3.
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In these same calves, it was also observed that following an infectious bovine rhinotracheitis 
virus challenge, the calves that received the Cr-nicotinic acid complex tended to have lower 
body temperatures compared with the CrCl3-fed and control-fed calves. Serum cortisol 
concentrations were also lower in the Cr-fed compared with the control-fed calves. 
Lymphocyte blastogenic response to phytohemagglutinin and pokeweed mitogen were not 
affected by Cr. These authors concluded that Cr supplementation may enhance immunity 
and, thus, increase disease resistance in young calves. Specific high affinity insulin receptors 
have been found on bovine peripheral blood mononuclear cells (Mcbride et al., 1989) and 
the functional capacity o f cultured bovine peripheral blood mononuclear cells has been 
found to be affected by insulin (Burton et al, 1993). Some studies, but not others, and some 
immunological measurements, but not all, suggest that Cr is probably important in immune 
modulation. Speculation would seem to suggest that the action o f Cr on immune responses 
are similar to what has been suggested for its effect on carbohydrate and lipid metabolism. 
That is by improving the insulin sensitivity of immune cells. Glucose uptake by immune cells 
is insulin dependent. Therefore improving insulin’s effectiveness may ensure that energy 
(i.e., glucose) is available so that the immune cells can carry-out their required functions. 
It is also known that as insulin sensitivity decreases, such as with a diabetic individual, 
immune responsiveness also decreases (Mangrum and Bakris, 1997).
Chromium Effects on Growth Performance
Since the early sixties, growth performance (i.e., rate o f gain, feed intake, feed 
efficiency) has been measured in laboratory animals fed a variety o f diets supplemented with 
inorganic and organic Cr sources. Supplemental Cr to typical laboratory rat and mice diets
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have been reported to increase rates o f gain (Schroeder et al., 1963a,b; Schroeder, 1965; 
Schroeder 1966; Mertz and Roginski, 1969). In addition, Schroeder (1965) compared 
growth curves o f Cr-fed and control-fed rats and mice and concluded that the largest 
increases seemed to occur around weaning. In studies that have investigated whether there 
was an interaction between supplemental Cr and sex, most reported no effect o f sex 
(Schroeder et al., 1963b; Schroeder, 1965; Schroeder 1966), although one study (Mertz and 
Roginski, 1969) reported the supplemental Cr enhanced the growth rate o f females to a 
greater degree than that o f males. Two more recent reports failed to find any beneficial 
improvements on performance in rats fed supplemental Cr (Hasten, 1994; Bush, 1997). 
Why some studies conducted with laboratory animals have reported that supplemental Cr 
improves some performance criteria and other similarly conducted studies have failed to find 
a difference is not readily apparent. However, one theory that has been suggested is that 
these inconsistencies may be because o f an individual animal's Cr status, prior to the time 
supplementation was begun. That is, animals that are already adequate in Cr may not show 
a response to supplemental Cr. Mooradian and Morely (1978) suggested that improvements 
from Cr supplementation will be most likely to take place only in Cr-deficient subjects. In 
addition, the use o f different Cr sources and the bioavailability o f those sources may also be 
a contributing factor to  the lack o f consistency between studies.
Chromium effect on performance criteria have also been variable in studies 
conducted with livestock. As suggested for the laboratory animals, initial Cr status may be 
a contributing factor. Furthermore, formulating Cr-free diets for livestock is less practical 
than for laboratory animals. Therefore it is even more difficult to ensure that the only
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source o f Cr that the animal receives is that which is part o f  the treatment. Possibly as a 
result o f these limitations, Cr supplementation studies conducted with livestock have been 
shown to either result in slight increases (Chang and Mowat, 1992; Page et al., 1993; Chang 
et al., 1995), or have no effect (Bunting et al., 1994; Chang and Mowat, 1992; Evock- 
Clover et al., 1993; Kitchalong et al., 1995; Lindemann et al., 1995; Page et al., 1993; 
Chang et al., 1995) on growth performance.
In pigs, some studies have reported greater growth rates in Cr-fed compared with 
control-fed (Page et al., 1993; Van Heugten and Spears, 1994) while others have reported 
no effect o f supplemental Cr (Evock-Clover et al., 1993; Ward et al., 1994). In newly 
arrived market-transit calves, Chang and Mowat (1992) reported that addition o f .4 ppm Cr 
as a high-Cr yeast to the ration improved ADG (average daily gain) by 30% and feed 
efficiency by 27% during the 1“ 28 d after arrival in the Cr-fed calves compared with 
control-fed calves that did not receive an oxytetracyciine injection, but not compared with 
the control-fed calves that received an oxytetracyciine injection within 48 h after arrival. 
Moonsie-Shageer and Mowat (1993) showed a linear relationship between Cr intakes (0 to 
1 ppm) and growth performance responses during the initial 28 d after arrival o f transit- 
stressed feeder steers. However, in this study, performance responses were again similar 
after calves were switched from receiving to finishing rations. In stressed feeder calves, 
supplementation of Cr at .5 ppm to the ration as an amino acid-Cr chelate has also been 
reported to improve ADG (Mowat et al., 1993). However, in this study, growth 
improvements were attributed to fewer morbid calves in the Cr supplemented group.
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Supplementation o f .37 ppm Cr as chromium picolinate to nonstressed calves fed 
com-cottonseed hull basal diets over a 56-d period did not affect ADG, DMI, or feed 
efficiency (Bunting et al., 1994). Likewise, no differences were observed on gain, intake, 
or efficiency when supplementing .2 ppm Cr from high Cr yeast to growing (70 d) and 
finishing (68 d) cattle (Chang et al., 1992). In lambs receiving high concentrate rations, 
addition of Cr as Cr picolinate was also reported to  have no effect on ADG or feed intake 
(Kitchalong et al., 1995). In calves fed milk alone through the initial 9-wk o f life, 
supplementation with Cr as CrCl3 or a Cr nicotinic acid complex did not affect rate o f gain 
or feed efficiency compared with control-fed calves (Kegley et al., 1997a).
Most reports on changes in body composition in response to addition of 
supplemental Cr to rations have been reported in studies conducted with pigs, as opposed 
to ruminants. In pigs the more commonly observed effects o f Cr supplementation on 
carcass changes seem to be increased longissimus muscle area and decreased tenth rib fat 
thickness (Page et al., 1993; Smith et al., 1994; Lindemann et al., 1995). In sheep, 
Kitchalong et al. (1995) also reported that Cr picolinate reduced tenth rib fat thickness and 
also showed there was a tendency for a decrease in pelvic frit. In cattle, Chang et al. (1992) 
and Mathison and Engstrom (1995) reported that Cr supplementation did not affect any o f 
the carcass measurements taken; however, Claeys et al. (1994) did report higher quality 
grades for Cr-fed compared with control-fed steers.
Chromium Effects on Milk Production
Glucose uptake by the mammary cells appears to be independent o f the action of 
insulin (Brockman, 1986). Therefore, it would appear that there would be little benefit from
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Cr supplementation on milk production. However, emerging data from lactation studies 
suggests that supplemental Cr may increase milk yield during early lactation (Yang et al., 
1996, Besong et al., 1996). Although it is not clear how supplemental Cr may increase milk 
yield in early lactation, one possibility is that a slight reduction in the rate of mobilization o f 
fatty acids from adipose tissue may simply help stabilize hepatic fat metabolism, reduce 
hepatic ketogenesis, and perhaps allow feed intake to increase more rapidly after calving. 
However, only in the Besong et al. (1996) study was the increase in milk yield accompanied 
by increased feed intake. Yang and co-workers (1996) postulated that increased milk yield 
may be the result of the indirect effects o f Cr on gluconeogenesis. Subiyatno et al. (1996) 
in early lactation heifers and Sano et al. (1996) in stressed rams showed that, following an 
i.v. propionate loading test, the conversion o f propionate to glucose increased in those 
animals receiving supplemental Cr. This suggests that Cr may, by some yet unknown 
mechanism, increase gluconeogenesis. A more direct hypothesis for the increase in milk 
production might be that Cr promoted the activity of the insulin-like growth factor (IGF) 
receptors, because IGF receptors have a structural and functional homology similar to that 
of insulin receptors (Yang et al., 1996). Subiyatno and co-workers (1996) showed trends 
for increased circulating IGF-1 in Cr supplemented, early lactation cows following a 
propionate challenge.
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PERFORMANCE AND METABOLIC RESPONSES OF 
PRE- AND POST-WEANING HOLSTEIN CALVES 
SUPPLEMENTED WITH CHROMIUM PICOLINATE
Introduction
Chromium is well established as an essential trace element for man and laboratory 
animals (Anderson, 1987; Mertz, 1993). Chromium appears to be an integral component 
of a molecular complex known as the glucose tolerance factor which facilitates the cellular 
binding and action of insulin. There is increasing evidence that Cr may be a required 
nutrient in livestock diets. Supplemental Cr has improved glucose tolerance and has 
improved a number o f production parameters in swine (Page et al., 1993; Amoikon et al., 
1995). In ruminants, positive production responses to supplemental Cr seem to depend 
upon the presence o f  stressors, such as "market-transit" stress (Chang and Mowat, 1992; 
Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993) or early lactation (Subiyatno et 
al., 1996). Supplemental Cr has had only modest effects on glucose tolerance or other 
indices o f carbohydrate metabolism in functional ruminants (Bunting et al., 1994; Kegley 
and Spears, 1995; Kitchalong et al., 1995; Subiyatno et al., 1996). However, functional 
ruminants derive little glucose from intestinal absorption and the role o f insulin in these 
animals is perhaps less well defined than in the nonruminant (Brockman, 1986).
Because glucose is absorbed in comparatively large quantities in the milk-fed 
ruminant, the importance o f insulin to glucose homeostasis is analogous to that o f the 
nonruminant. In addition, there is evidence that milk-fed calves become insulin resistant 
with age, resulting in exaggerated postfeeding elevations in insulin and glucose in the blood
33
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(Hostettier-Allen et al., 1994). Under these conditions, there is the potential for urinary 
spillage o f blood glucose and reduced efficiency. In addition, Grutter and Blum (1991) 
reported that insulin secretory mechanisms may not be fully developed in young calves. 
Therefore, it seems plausible that neonatal calves would be more metabolically responsive 
to Cr than adult cattle. The limited data that are available with milk-fed calves were not 
conclusive regarding the effects of supplemental Cr on carbohydrate metabolism (Kegley 
et al., 1997a). The study described herein was conducted to more clearly delineate the 
effects o f  supplemental Cr on carbohydrate metabolism in conventionally-fed calves from 
birth through weaning.
Materials and Methods
Animals and Feeding. Forty-two Holstein calves bom at the campus dairy farm in 
Baton Rouge, were used in an experiment approved by the Institutional Animal Care and 
Use Committee of the LSU Agricultural Center. Although the calves were bom over a five- 
month period (August 23 to December 5,1994), the experimental period for each calf lasted 
from 4 d to around 8 wk (d 53 ± 3) of age. Calves were removed from their dams within 
24-h o f birth, weighed, and individually housed in 2.5-m2 hutches with a  2.3-m2 wire 
enclosure attached to the hutch. During the first 3 d after birth, calves received colostrum 
only (1.9 liters twice daily) and were trained to drink from buckets. Any colostrum not 
voluntarily consumed was fed by bottle or esophageal feeding tube. Calves readily drinking 
from buckets and showing no apparent health problems at 3 d o f age were divided into sex 
and birth date peer groups, and then randomly assigned to treatment (11 male and 10 female 
calves per treatment). Treatment consisted o f diets either without (control) or with 1 ppm
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supplemental chromium (Cr). Chromium was supplied as chromium picolinate (CrP; 12% 
Cr; Nutrition 21, San Diego, CA).
Beginning on d 4 and until 5 wk of age (weaning), calves received a commercial milk 
replacer with a guaranteed analysis o f  22% CP and 15% fat (Nurstrate®, Moorman’s, Inc, 
Quincy, IL ) . Each calf received 250 g o f DM as milk replacer in 1600 mL o f 40+1° C tap 
w ater at 0800 and 1600 daily until weaning. Chromium picolinate is poorly soluble in 
water, hence, to ensure complete consumption, the entire daily allotment was suspended in 
15% of the evening feeding and given via a bottle until calves were weaned. On d 4 and 5 
o f age, Cr-supplemented calves received a priming dose o f 21 mg o f  Cr daily and from 6 d 
o f  age until weaning they received 4.2 mg/d o f  Cr. After calves were weaned CrP, in a 
dextrose carrier, was supplemented in the starter.
On the morning following collection o f  wk 2 blood samples calves were offered a 
commercial calf starter with a guaranteed analysis o f  at least 16% CP and 2% fat (Purina® 
commercial calf starter/grower (coarse) BVT 60; Purina Mills, Inc, St. Louis, MO). Starter 
intake was recorded and fresh feed offered at each feeding. When a calf had consumed all 
o f  its starter between feedings, an additional 100 g o f starter was offered. All calves were 
weaned at around 5 wk o f age at an average starter intake of .96 kg/d.
Sample Collection and Metabolic Challenges. Body weight (BW) measurements 
were taken shortly after birth and at noon when calves were around 2, 4, and 8 wk old. At 
1, 2, 3, 4 and 5 wk of age, blood was collected immediately before (prefeeding) and 2 h 
after (postfeeding) the evening meal by jugular venipuncture into 7-mL evacuated tubes
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containing potassium oxalate and sodium fluoride (Sherwood MedicaL, St. Louis, MO). 
Postfeeding blood sampling was discontinued for the last eight calves added to the study.
Metabolic challenges were conducted on half the calves. An i. v. glucose tolerance 
test (TVGTT) was conducted at the end o f the 2nd wk of life (the d prior to starter access) 
and during the 8th wk of life to measure the calves abilities to clear a glucose load. A 
propionate loading test (PLT) was also conducted on the same calves during the 8th wk of 
life to measure the effects of Cr supplementation on gluconeogenic potential. The IVGTT 
was performed 4 h after the morning milk feeding at 2 wk of age and after an overnight fast 
(16 h) at 8 wk of age. Calves were fitted with 14-G jugular catheters (Quik-Cath®; Baxter 
Healthcare, Deerfield, EL) and were allowed at least 1 h of rest prior to the IVGTT. The 
IVGTT consisted o f infusing a glucose solution (500 mg/kg of BW in a 50% w/v solution 
in sterile saline) as an i.v. bolus dose over a 30- to 60-s interval. Prior to infusion of 
glucose, one blood sample was drawn (0 min) and then glucose was administered (1 mL/kg 
BW) i.v. through the catheter. Blood was then drawn at 10, 15,20, 30, 40, 50 and 60 min 
relative to glucose infusion. Following completion of the IVGTT conducted at 8 wk o f age, 
calves were given access to water only during a 2-h rest period prior to beginning the PLT. 
The PLT consisted of a pulse i.v. infusion o f  propionate (3 mmol o f Na-propionate/kg BW 
as a 1.84 M solution in sterile saline) over a 2-min interval. Blood samples were collected 
prior to and 5, 10, 15, 20, 40, 60, 90, and 120 min relative to propionate infusion. To 
ensure that none of the infusion solutions remained in the catheter sheath, following infusion 
o f  glucose or Na-propionate, sterile saline (5 mL) was flushed through the catheter. 
Catheter patency was maintained with 6% sodium citrate in sterile saline.
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Blood Processing and Analyses. Blood samples were placed in ice immediately after 
withdrawal and were centrifuged within 1 h at 3,000 x g for 10 min at 4°C to obtain plasma. 
Plasma was harvested and stored at -15°C. Weekly blood samples were analyzed for 
plasma glucose, insulin, and nonesterified fatty acids (NEFA) concentrations in the 0 and 
2 h samples, whereas plasma cortisol and IGF-1 concentrations were determined only in the 
prefeeding samples. Commercial kits were used in the colorimetric determination of plasma 
glucose (Sigma Tech. Bull. No. 315; Sigma Chemical, St. Louis, MO) and NEFA (NEFA-C 
Kit; Wako Chemicals USA, Richmond, VA). Plasma cortisol was determined by a 
commercial kit (Cortisol RIA Kit No.DSL-2000; Diagnostic Systems Laboratories Inc., 
Webster, TX.). Plasma insulin and IGF-1 were determined by RIA as described by Sticker 
et al. (1995). For blood samples collected during the PLT, propionate was precipitated as 
a Na salt from deproteinized plasma as described by Ryan (1980). The propionate salt was 
resuspended in water and subjected to standard gas chromatography (Shimadzu GC-17A, 
Shimadzu Scientific Instruments, Inc., Columbia, MD) with samples corrected to 100% 
recovery using 2-ethybutyric acid as an internal standard.
Statisrical Methods and Calculations. Glucose and propionate clearance rates were 
computed for each calf following the IVGTT or PLT, respectively (Kaneko, 1989). 
Intervals used to compute glucose clearance rate were 15 to 30 min and 10 to 40 min for 
the IVGTT and PLT, respectively. The interval to compute propionate clearance rate was 
5 to 20 min for the PLT. Changes in plasma glucose in response to the IVGTT and PLT 
were further evaluated by computing area under the response curves (AUC) relative to basal 
levels using trapezoidal geometry.
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Data for initial BW, starter intake, and kinetic analysis o f  metabolite challenges were 
analyzed by least squares ANOVA and PROC GLM of SAS (SAS®, 1989). The model was 
a factorial including treatment, sex and treatment by sex interaction. Analysis o f  final and 
intermediate BW measurements and feed efficiency included birth weight as a covariable. 
Data for prefeeding and postfeeding hormone and metabolite concentrations were analyzed 
as a split-plot. In the whole plot, treatment, sex and treatment by sex were tested against 
calf (treatment x sex) means square. In the sub-plot, calf age (wk) and all interactions of 
age with treatment and sex were tested against residual mean square. The PROC 
UNIVARIATE procedure o f  SAS (SAS®, 1989) was used to test for normality and a 
Shapiro-Wilks test value of 0.1 was selected for rejection o f  the null hypothesis. When 
normality was rejected, data transformation was used to achieve normality and transformed 
values analyzed. Means are reported in original units and all statistical analyses were 
conducted using the GLM procedure o f SAS (SAS®, 1989). Aside from the previously 
mentioned blood samples that were not collected there was one CrP-fed heifer in which only 
performance data was collected and one CrP-fed bull in which only its weekly blood variable 
measurements and performance data through wk 2 were used.
Results and Discussion
Performance. Twenty-two male and twenty female Holstein calves entered the trial 
at 4 d o f age. Aside from minor, controllable bouts o f scours that occurred primarily before 
weaning, calves were healthy throughout the trial. Calves averaged 38.5 ± 4 kg at birth and 
gained an average o f 27.8 ±  6.5 kg over the 8 wk trial. As expected, rate o f weight gain 
was influenced by the age o f the calf (P -  .0001). Average daily gain was lowest while
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calves were fed milk only (. 17 ± . 13 kg/d/calf) and increased exponentially ( r  = 1) over the 
ensuing 2 to 3-wk weighing intervals. Over the initial 2-wk interval that calves had access 
to starter, calves gained an average o f .36 ± . 16 kg/d, and over the final 2- to 3-wk interval 
calves gained an average o f  .77 ± . 13 kg/d. Over the entire trial, calves gained an average 
o f .50 ± . 1 kg/d and .47 ±  .05 kg o f BW was gained per kg o f DM intake. Starter intake 
was minimal (less than .22 kg/d) between 2 and 3 wk o f age, then steadily increased (P = 
.0001) throughout the remainder o f the experiment. Based on three-day-averages, starter 
intakes (as-fed) o f .45, .68, .91, 1.36, and 1.84 kg/d were reached at 28 ± 4, 32 ± 4, 35 ± 
4, 39 ± 4, and 44 ±  5 d o f age, respectively.
In calves, rate o f gain characteristically increases exponentially throughout the first 
several months o f life (Roy, 1980). Reported ADG can also be influenced by differences 
in feeding regimes and differences in the time frames used to report daily gains. These 
inherent and imposed differences between studies make comparing rates o f gain from one 
study to the next difficult. Through the first 90 d o f life, a desirable rate o f gain for dairy 
herd replacements has been suggested to be about .875% of birth weight daily or about .42 
kg/d (Roy, 1980). This is about .08 kg/d less than observed in the current trial. Holstein 
calves fed milk alone and milk plus grain and (or) hay over the initial 28 d o f life have been 
reported to gain .26 kg/d and .53 kg/d, respectively (Quigley et al., 1991). Estimates o f 
growth rates in Holstein calves during the first several months o f life have ranged from .39 
to .66 kg/d across a variety o f feeding regimes (Doppenberg and Palmquist, 1991; Quigley 
et al., 1991; Quigley and Bernard, 1992; Kegley et al., 1997a).
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The effects o f Cr supplementation and sex on rate o f gain were analyzed over three 
intervals: 1) milk-fed only, 2) starter plus milk, and 3) over the entire trial. For all the 
intervals investigated ADG did not differ (P > .10) between calves fed control or Cr- 
supplemented milk replacers or between bulls and heifers (Table 3 .1). However, when 
calves received milk alone, there was a tendency for bulls given supplemental Cr to gain 
more weight and for heifers given supplemental Cr to gain less weight compared to control- 
fed calves (treatment x sex; P = . 15; Table 3.1). This tendency was not evident once calves 
began receiving starter (treatment x sex; P = .27); however, over the entire trial, bulls given 
supplemental Cr gained more weight and heifers gained less weight than control calves 
(treatment x sex; P = . 10; Table 3.1). Kegley et al. (1997a) reported that supplementation 
with either organic or inorganic Cr had no effect on rate o f gain or feed efficiency in 
Holstein bull calves fed milk alone during the first 9 to 10 wk o f life. In older calves, 
supplemental Cr has been reported to improve performance in some studies (Moonsie- 
Shageer and Mowat, 1993; Mowat et al., 1993) but not others (Bunting et al., 1994; Kegley 
and Spears, 1995). Starter intakes did not differ between treatments or sexes (P > .10; 
Table 3 .1). When calves were fed only milk, all calves received the same amount o f DM 
daily. It is possible that, because bulls were slightly (P = .17; Table 3.1) larger than heifers 
at birth, bulls may have been more nutrient deficient than were the heifers.
Plasma Metabolites and Hormones. Regardless o f calf age, sex did not affect (P > 
.10) pre- and postfeeding blood metabolite concentrations; hence, only the effects o f  dietary 
treatment and age are presented in Tables 3.2 and 3.4. With the exception o f prefeeding 
NEFA (below), there were no interactions (P > . 10) between treatment and age for any o f
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Table 3.1. Least squares means for BW gain and starter intake in calves supplemented with chromium picolinate.
Treatment
Control Chromium P > F1
Item
Bulls Heifers Bulls Heifers SEM Treatment Sex
Treatment 
x Sex
nJ 11 10 11 10
Initial BW, kg 40.5 36.9 38.5 38.2 1,36 .83 .17 .22
BW gain, kg/d
week 0 to 23 .15 .21 .18 .12 .04 .40 .99 .15
week 0 to 8 .47 .53 .53 .48 .03 .76 .94 .10
week 2 to 84 .60 .63 .66 .62 .04 .52 .90 .27
Starter intake, kg of DM/d 
(week 2 to 8) .92 1.04 1.09 1.02 .08 .36 .75 .25
'Probability of greater F-value.
^For one bull calf in the CrP treatment only its initial and week 2 BW data were used.
3Period during which calves received only milk.
'Period during which calves received milk plus grain (week 2 to 5) and grain only (week 5 to 8).
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the prefeeding or feeding-response plasma metabolite concentrations measured in this 
experiment (Tables 3.2 and 3.4). Generally, the plasma glucose response to feeding 
increased until calves were about 3 wk o f  age and then declined to wk 5 o f age (age effect; 
P = .003; Table 3.2). This age-related pattern was more obvious in Cr-supplemented calves; 
however, glucose responses in calves fed the control milk replacer were relatively consistent 
from one wk to the next (treatment x age trend; P = . 12; Table 3.2). The physiological 
relevance o f  this observation relative to the effect o f Cr on insulin function is not clear. 
Chromium had no independent effects (P > .10; Table 3.2) on pre- or postfeeding 
concentrations o f glucose or insulin. When intensively-fed veal calves consumed a normal 
meal, plasma glucose concentrations have been observed to rise above the assumed renal 
threshold for urinary glucose excretion in calves (Hostettler-Allen et al., 1994). The renal 
threshold for calves has been estimated at between about 8 and 10 mM (Wijayasinghe et al., 
1984; Scholz and Hoppe, 1987; Hostetder-AUen et al., 1994). Hostettler-Allen et al. (1994) 
concluded that urinary glucose loss was probably only a transient phenomenon, but 
represented a potential source o f lost energy that could contribute to reduced feed utilization 
and growth performance; however, in their study, ADG and gain:feed ratio by calves was 
not visibly diminished. In our study, plasma glucose concentrations rarely exceeded 8 mM 
and then, only at 1 wk o f age.
In contrast to plasma glucose, plasma insulin increased by 38% from 1 to 5 wk of 
age (age effect, P = .09; Figure 3.1), although the magnitude o f the plasma insulin response 
to feed was not affected (P = . 19; Table 3.2) by the age o f the calf. The gradual divergence 
o f plasma glucose and insulin concentrations with age (Figure 3.1) could have at least two
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Table 3.2. Least squares means for plasma glucose and insulin concentrations 
at weekly intervals prior to (Pre) and 2 h after feeding (Post)1 
____________in calves supplemented with chromium picolinate.____________
Glucose Insulin
Treatment2
Age,
weeks Pre Post change3 Pre4 Post4 change5
---- (mM)----- (%) ----- (ng/ml)------ (%)
Control
1 5.31 
(5.1, 5.5)6
6.43 
(6.1,6.8)
21.3 
(13, 30)
.28 
(.21, .37)
1.97 
(1.3,2.9)
554.8
(297, 955)
2 5.21 
(5.0, 5.4)
6.51 
(6.1,6.9)
24.2
(16,34)
.30 
(.23, .40)
1.01 
(.7, 1.5)
221.0 
(87,435)
3 4.90 
(4.7,5.1)
6.25 
(5.9,6.6)
26.0 
(17. 36)
.34 
(.25, .44)
1.41 
(1.0,2.1)
177.1 
(60,366)
4 4.62
(4.4,4.9)
5.94
(5.6,6.3)
26.7 
(18, 37)
.33
(-25, .44)
1.58 
(1.1,2.3)
374.0 
(182,675)
5 4.55 
(4.3,4.8)
5.58 
(5.2,5.9)
19.6
(12.28)
.36 
( 2 1 , .47)
1.84
(1.3,2.7)
378.3 
(185, 682)
Chromium
1 5.37 
(5.1, 5.6)
6.04
(5.7,6.4)
8.4
(2, 16)
.30 
( 22, .40)
1.41
(.9,2.1)
326.2
(148,613)
2 4.99
(4.7, 5.2)
6.26
(5.9, 6.6)
25.1 
(16, 35)
.26
( 20, .35)
.93 
(.6, 1.4)
218.8 
(82,442)
3 4.70
(4.4,4.9)
6.27 
(5.9,6.8)
34.0
(24,46)
.31 
(.23, .42)
1.28
(-8,2.0)
296.3 
(124, 580)
4 4.48
(4 2 , 4.7)
6.06
(5.7,6.5)
33.1
(23,45)
.37 
(.28, .50)
1.34
(.9,2.0)
223.2
(81,460)
5 4.57 
(4.3,4.8)
5.73 
(5.3, 6.1)
20.9
(12,31)
.45
(.33, .61)
2.40 
(1.6, 3.7)
432.7 
(206, 800)
P > F7
Treatment .44 .72 .98 .84 .74 .72
Age .0001 .002 .003 .09 .004 .19
Treatment
xage .69 .55 .12 .70 .67 .53
(Table con’d.)
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‘For prior to feeding (Pre) variables, n = 21 and 20 calves for control and chromium means, 
respectively, and for 2 h after feeding (Post) and percentage change variables, n = 17 and 
16 calves for control and chromium means, respectively 
2There were no interactions o f treatment or age with sex (P > . 10).
’For statistical analysis, the percentage change in glucose original values were transformed 
by raising the original values to the .4 power.
4For statistical analysis, the Pre and Post insulin original values were transformed by taking 
the natural log o f the original values.
’For statistical analysis, the percentage change in insulin original values were transformed 
by raising the original values to the . 1 power.
6With the exception o f Pre and Post glucose variables, all means are based on analysis of 
transformed data; consequently, the lower and upper 95% confidence limits for each mean 
are given in parentheses.
’Probability o f  a greater F-value.
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Figure 3.1. Weekly prefeeding concentrations o f  plasm a glucose and insulin. 
Solid line =  glucose; dash line = insulin.
0 -3 -  ^
0.2u,
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2 3 4 51
Week o f  Age
Figure 3.2. W eekly prefeeding and 2 hours after feeding concentrations o f  
plasm a nonesterified fatty acids (NEFA). Solid line =  basal; dash line = 2 
hours after feeding; square = control; circle = chromium picolinate.
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unique developmental components. First, insulin insufficiency appears to be a common 
characteristic o f neonates, as pancreatic insulin release is limited for the 1st few d or wk o f 
life. For example the capacity to clear a load of glucose increases measurably within the 1 st 
wk o f life in humans (Baird and Farquhar, 1962; Bowie et al., 1963; Falomi et al., 1974), 
between the 2nd and 4th wk of life in rats (Issad et al., 1987), and between the 7th and 8th 
wk o f life in dogs (Varma et al., 1973). Similarly, Grutter and Blum (1991) reported the 
mechanisms o f insulin secretion may not be fully developed in young calves. Secondly, there 
is evidence suggesting that tissue sensitivity to insulin is adequate in the young preruminant 
animal but begins to decline as the rumen begins to develop (Weekes et al., 1983; Metcalf 
and Weekes, 1990; Grutter and Blum, 1991; Sano et al., 1991). Thus, the data from the 
present experiment may indicate that, as the calves become older, more insulin was required 
to maintain a declining homeostatic level of glucose. That is, calves may have gradually 
become less insulin sensitive with age.
By the time the second IVGTT was conducted at 8 wk o f age, prefeeding plasma 
glucose concentrations were some 20% lower than during the first IVGTT conducted at 2 
wk o f age (Table 3.3). It was interesting that glucose clearance rates were almost 40% 
faster at 2 wk o f age compared with 8 wk o f age when the calves were fully functional 
ruminants. Although not statistically testable, this may again indicate that the calves were 
becoming less insulin sensitive. At 2 wk of age, heifers had higher (P = .10) glucose 
clearance rates than bulls; however, this effect had all but disappeared (P = .67) by 8 wk o f 
age. Supplemental Cr had no influence on (P > .10) on basal plasma glucose, glucose 
clearance rate or AUC at either 2 or 8 wk o f age. When Cr was supplemented as Cr-
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Table 3.3. Least squares means for kinetic response variables during i.v. infusions of glucose and propionate
Treatment Sex
Item Control Chromium SEM P > F2 Bulls Heifers SEM P > F2
n 10 11 10 11
IVGTT3
2 weeks of age
Basal glucose concentrations, mM 5.05 4.90 .22 .64 4.76 5.18 .22 .19
Glucose clearance rate, %/min 2.24 2.22 .38 .96 1.76 2.70 .38 .10
Glucose AUC, min-mM 145 161 29 .71 173 134 29 .36
8 weeks of age 
Basal glucose concentrations, mM 4.02 3.91 .22 .73 3.80 4.13 .22 .31
Glucose clearance rate, %/min 1.59 1 16 .19 .12 1.32 1.43 .19 67
Glucose AUC, min-mM 301 320 23 .57 314 308 23 .84
PLT4
8 weeks of age 
Basal propionate concentrations, mM .57 .35 .10 .15 .42 .50 10 .61
Propionate clearance rate, %/min 7.02 8.24 .85 .33 7.75 7.51 .85 .84
Basal glucose concentrations, mM 3.92 3.54 .26 .30 3.64 3.82 .26 .63
Glucose AUC, min-mM 90 70 20 .51 20 139 21 .001
(Table con’d.)
Reproduced 
with 
perm
ission 
of the 
copyright ow
ner. 
Further reproduction 
prohibited 
without perm
ission.
'There were no (P > . 10) treatment interactions.
Probability of a greater F-value.
3Kinetic criteria from i.v. glucose tolerance test (IVGTT): basal concentrations immediately prior to challenges; clearance rate computed 
from 15 to 30 min after glucose challenge and area under the response curve (AUC) from 0 to 60 min.
4Kinetic criteria from propionate loading test (PLT): basal concentrations immediately prior to challenge; propionate clearance rate calculated 
from 5 to 20 min after propionate infusion and glucose area under the response curve (AUC) from 0 to 60 min.
•t*
00
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nicotinate or CrCl3, glucose clearance rate during an IVGTT was not affected in 9-wk old 
Holstein bull calves fed only milk (Kegley et al., 1997a) or in feeder calves (Kegley and 
Spears, 1995). In contrast, glucose clearance rate during an IVGTT was 40 and 47% faster 
in steers and heifer feeder calves respectively, when the calves were supplemented with Cr- 
picolinate (Bunting et al., 1994).
During the PLT, basal levels o f  propionate and glucose in the blood were similar (P 
> .  10) for all calves (Table 3.3). Supplemental Cr affected (P > . 10) neither the propionate 
clearance rate nor the blood glucose response (glucose AUC) to the PLT. Although the 
heifers and bulls cleared their propionate loads at similar rates (P = .33), heifers had a much 
greater (P = .001) plasma glucose response to the propionate challenge than did bull calves. 
When combined with the finding of greater glucose clearance rates during IVGTT by heifers 
at 2 wk o f age, this finding may indicate that there are innate differences in glucose 
metabolism between males and females, at least within the Holstein breed.
Plasma NEFA concentrations, measured both prior to and 2-h after feeding, declined 
with age in all calves (P = .0001; Table 3.4). However, the magnitude of the increase in 
blood NEFA concentrations following milk replacer consumption became much greater as 
the calves grew older (age effect; P = .002; Table 3.4). It is worth noting that plasma 
NEFA concentrations typically decrease in most animals following consumption o f  meal. 
This is largely because o f insulin’s actions to decrease lipolysis and increase reincorporation 
o f fatty acid into adipocytes. Chilliard (1993) noted that NEFA concentrations in ruminants 
receiving a high level o f fat averaged 13% greater than the mean o f control groups. 
Chilliard postulated that circulating NEFA concentrations become elevated because o f
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Table 3.4. Least squares means for plasma nonesterified fatty acids (NEFA), cortisol, and 
insulin-like growth factor-1 (IGF-1) concentrations at weekly intervals prior to (Pre) and 
^h^fte^fe^in^Post2M n^dvessu£glem ait^witJ^hronuun^icolinat^^^^^^
NEFA Cortisol IGF-1
Treatment2
Age,
weeks Pre3 Post3 change3 Pre3 Pre3
—  (mM) — (%) -------- (ng/ml)---------
Control
1 .25 
(.20, ,30)4
.29 
(.25, .33)
27.8 
(1.9, 60.4)
5.92 
(4.45, 7.87)
8.87
(7.8, 10.0)
2 .15 
(.12, .18)
.22 
(.19, .25)
58.4
(27.3,97.1)
2.37 
(1.78, 3.15)
9.13 
(8.0, 10.4)
3 .10 
(-08, .12)
.22 
(.19, .25)
99.7 
(59.2, 150.5)
.92 
(.68, 1.23)
9.38 
(82,10.7)
4 .12
(.10,-15)
.18
(.16, .21)
59.8 
(28.4, 98.9)
.70
( 53, .93)
10.99
(9.6, 12.6)
5 .09
(.07, .11)
.20 
(17, .22)
128.1 
(80.1, 188.9)
.58 
( 44, .78)
15.23 
(13.3, 17.4)
Chromium
1 .20 
(.16, .24)
.22 
(.19, .25)
23.4 
(-1.6,54.9)
7.00 
(5.23, 9.38)
7.90
(6.9, 9.1)
2 .13 
(-11,.16)
.19 
(.16, .22)
69.4
(31.1, 118.9)
2.43
(1.81,3.25)
8.91
(7.7, 10.3)
3 .12 
(.10, .15)
.20
(.17,-22)
44.0
(13.7,82.4)
1.12 
(.83, 1.51)
10.34
(9.0, 11.9)
4 .08
(.07, .10)
.16
(-14,-18)
92.5 
(52.1, 143.8)
.89 
(.66, 121)
12.34
(10.7, 14.2)
5 .09
(.07, .11)
.18
(.16, -21)
117.5 
(69.6, 178.8)
.69 
(-51. .93)
16.45 
(14.3,18.9)
P > F5
Treatment .12 .01 .72 .40 .80
Age .0001 .0001 .0002 .0001 .0001
Treatment x
age .04 .62 .25 .96 .42
(Table con’d)
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‘For prior to feeding (Pre) variables, n = 21 and 20 calves for control and chromium means, 
respectively, and for 2 h after feeding (Post) and percentage change variables, n = 17 and 
16 calves for control and chromium means, respectively.
2There were no interactions o f treatment or age with sex (P > . 10) except for basal NEFA 
concentrations (treatment x age x sex; P = .05).
3For statistical analysis, the original values for all variables were transformed by taking the 
natural log o f the original values.
4A11 means are based on analysis o f transformed data; consequently, the lower and upper 
95% confidence limits for each mean are given in parentheses.
’Probability o f a greater F-value.
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incomplete removal o f free fatty acids into tissue adipocytes following the action o f 
lipoprotein lipase on chylomicrons and lipoproteins. The milk replacer used in this study 
contained 15% fat (DM basis) which would be some five times greater than the level o f  fat 
typical of a post-weaning ruminant diet. Compared with control calves, prefeeding plasma 
NEFA were lower in calves given Cr-supplemented milk replacer in the first wk of life; 
however, because blood NEFA declined more rapidly in control calves, calves in the two 
treatments had similar prefeeding plasma NEFA concentrations by 5 wk o f age (treatment 
x age; P = .04; Figure 3.2). When measured 2-h after feeding, plasma NEFA concentrations 
from 1 to 5 wk o f  age were lower for calves fed Cr-supplemented compared with the 
control milk replacer (. 19 vs. .22 mM; P =  .01; Table 3.4). Supplemental Cr has reduced 
blood lipid concentrations in humans and laboratory animals (Doisy et al., 1976; Liu and 
Morris, 1978; Anderson et al., 1988; Mertz, 1992; Mertz, 1993), as well as in ruminants 
(Samsell and Spears, 1989; Bunting et al., 1994; Kitchalong et al., 1995; Yang et al., 1996). 
The mechanism o f action o f Cr on lipid metabolism is not well understood. However, Mertz 
(1993) suggested that the primary hypolipidemic effects o f organic Cr may be simply 
attributable to the aforementioned effect o f  insulin in decreasing lipolysis and increasing 
reincorporation o f  fatty acids into adipocytes.
Concentrations o f  plasma cortisol were not affected (P > . 10) by Cr supplementation 
or sex of the calves; however, by 5 wk o f  age, plasma cortisol concentrations were about 
10% of the concentrations observed at 1 wk o f age (age effect; P = .0001; Table 3.4). This 
is consistent with what has previously been reported for calves (Massip et al., 1977) and 
human infants (Wittekind et al., 1993), where concentrations have been observed to reach
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baseline adult concentrations by 2 to 3 wk of age. Cortisol levels could have an important 
role in the stress-susceptible neonate because, somewhere between the point o f  entry of 
glucose into the cells and its final degradation, cortisol directly delays the rate o f glucose 
utilization (Guyton, 1991). Hence, it is not unrealistic that Cr, via improved binding of 
insulin to its receptors, might help normalize blood glucose and (or) NEFA concentrations 
in the presence of high cortisol concentrations.
In chronically stressed cattle, Bennet et al. (1989) reported that high cortisol levels 
lead to hyperglycemia and elevated free fatty acids. In the short-term increased cortisol can 
provide a positive benefit by suppressing inflammatory responses; however, over prolonged 
periods, immune responses can be impaired such that relatively innocuous infections can 
escalate to the point of extreme morbidity (Goodman, 1988). Moonsie-Shageer and Mowat
(1993) first reported that addition of Cr to the feed o f “market-transit” stressed feeder 
calves lowered circulating cortisol concentrations, reduced morbidity, and increased growth 
during the first month after being transported from market to the experimental site; 
however, similarly conducted studies have not been able to confirm this response (Mowat 
et al., 1993; Wright et al., 1994; Chang et al., 1995). The finding that Cr did not affect 
cortisol concentrations in the present experiment is in agreement with findings that have 
been reported in sheep (Kitchalong et al., 1995; Forbes et al., 1998) and calves (Bunting et 
al., 1994; Kegley and Spears, 1995).
Concentrations of plasma IGF-1 were not affected (P > . 10) by Cr supplementation 
or sex o f the calves; however, by 5 wk of age, plasma IGF-1 concentrations had almost 
doubled in the calves (age effect; P = .0001; Table 3.4). In dairy heifers fed whole milk
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through weaning (8 wk o f age) and given access to hay and starter beginning at 3 and 4 wk 
o f age, respectively, IGF-1 concentrations were observed to gradually increase from wk 4 
to 12 and after wk 12 decreased (Hugi and Blum et al., 1997). To our knowledge, this is 
the first report o f IGF-1 concentrations in growing calves receiving supplemental Cr. 
Addition o f Cr to the rations o f lactating dairy cows did not afreet IGF-1 concentrations 
(Burton et al., 1995); however, in yearling ewes, there was a trend for increased IGF-1 
concentrations in lambs fed Cr-picolinate (Forbes et al., 1998). Growth hormone 
concentrations were not affected by Cr supplementation in feeder calves (Bunting et al.,
1994). The effects o f growth hormone on nutrient metabolism and tissue accretion are 
largely mediated through IGF-1. Among the specific effects o f  growth hormone are an 
increased rate o f protein synthesis and increased mobilization o f  fatty acids from adipose 
tissue (Guyton, 1991; Granner, 1996). Concentrations of IGF-1 in the blood of farm 
animals are positively correlated with developments o f skeletal mass and with the 
composition and rate o f body tissue deposition (Olsen et al., 1981; Buonomo et al., 1987; 
Anderson et al., 1988). Changes in circulating concentrations o f plasma IGF-1 are primarily 
regulated by energy balance and secondarily by protein in most animals (Underwood et al., 
1986; Ronge et al, 1988; Ronge and Blum, 1989).
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CHAPTER IV
PERFORMANCE AND METABOLIC RESPONSES OF PRE-WEANED HOLSTEIN 
CALVES FED A BASAL OR A HIGH LEVEL OF FAT IN MILK REPLACERS 
SUPPLEMENTED WITH CHROMIUM NICOTINATE
Introduction
Chromium (Cr) is well established as an essential trace element for man and 
laboratory animals (Anderson, 1987; Mertz, 1993). Chromium appears to be an integral 
component o f a molecular complex known as the glucose tolerance factor which facilitates 
the cellular binding and action of insulin; however, the exact mechanism(s) at the 
receptor/cellular level has not been clearly defined (Mertz et al., 1974; Govindaraju et al., 
1989; Mertz, 1993). There is increasing evidence that Cr may be a required nutrient in 
livestock diets. Supplemental Cr has improved glucose tolerance and a number of 
production parameters in swine (Page et al., 1993; Amoikon et al., 1995). In ruminants, 
positive production responses to supplemental Cr seem to depend upon the presence of 
stressors, such as, “market-transit” stress (Chang and Mowat, 1992; Moonsie-Shageer and 
Mowat, 1993; Mowat et al., 1993) or early lactation (Subiyatno et al., 1996). Supplemental 
Cr has been reported to improve immune responses and (or) disease resistance in cattle 
(Burton et al., 1993; Kegley et al., 1996; Kegley et al., 1997b). Supplemental Cr has had 
only modest effects on glucose tolerance or other indices of carbohydrate metabolism in 
functional ruminants (Bunting et al., 1994; Kegley and Spears, 1995; Kitchalong et al., 
1995; Subiyatno et al., 1996).
Because glucose is absorbed in comparatively large quantities in the neonatal 
ruminant, the importance o f insulin to glucose homeostasis is analogous to that of the
55
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nonruminant. Grutter and Blum (1991) reported that insulin secretory mechanisms may not 
be fully developed in young calves. In addition, there is evidence that milk-fed calves 
become insulin resistant with age, resulting in exaggerated postprandial elevations in insulin 
and glucose in the blood (Hostettler-Allen et al., 1993, 1994). Under these conditions, there 
is the potential for urinary spillage o f blood glucose and reduced efficiency. Therefore, it 
seems plausible that neonatal calves would be more metabolically responsive to Cr than 
adult cattle. The limited data that are available with pre-weaned calves are not conclusive 
regarding the effects of supplemental Cr on carbohydrate metabolism (DePew et al., 1995; 
Kegley et al., 1997a).
Supplemental fat has been reported to increase insulin resistance in lactating cattle 
(Palmquist and Moser, 1981). In addition, high-fat milk replacers have been reported to 
elevate blood glucose concentrations in Holstein calves (Wijayasinghe et al., 1984). In our 
previous study with pre-weaned calves fed a conventional milk replacer (Chapter 3), 
supplemental Cr elicited reductions in circulating NEFA, but no apparent effect on glucose 
homeostasis (i.e., glucose tolerance/insulin sensitivity). In the present study, pre-weaned 
calves were fed milk replacers with either a conventional or an elevated level of fat. Our 
objectives were to determine: 1) whether supplemental Cr would have a measurable effect 
on insulin sensitivity, if  greater insulin resistence is induced with added fat; 2) whether 
supplemental Cr would continue to reduce blood lipid levels when a higher level of dietary 
fat is eaten.
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Materials and Methods
Animals and Dietary Treatments. Thirty-four Holstein calves (21 bulls and 13 
heifers; 38.5 ± 6 kg initial BW), bom at the campus dairy farm in Baton Rouge, were used 
in an experiment approved by the Institutional Animal Care and Use Committee o f the LSU 
Agricultural Center. Although the calves were bom over a four-month period (November 
to February, 1996), the experiment period for each calf was from 4 d o f  age to around 5 wk 
o f age. Calves were removed from their dams within 24-h o f birth, weighed, and 
individually housed in 2.5-m2 calf hutches with a 2.3-m2 wire enclosure attached to the 
hutch. For the initial 3 d of life, calves received colostrum only (1.9 liters twice daily) and 
were trained to drink from buckets. Any colostrum not voluntarily consumed was fed by 
bottle or esophageal feeding tube. Calves readily drinking from buckets and showing no 
apparent health problems at 3 d of age were divided within birth date and sex peer groups 
and then randomly assigned to one o f four dietary treatment groups.
Dietary treatments, arranged in a 2 x 2 factorial, consisted o f  milk replacer with 
either a basal level o f fat (15% o f DM as fat; BF) or a high level o f fat (22% of DM as fat; 
HF) fed either without (control) or with supplemental chromium (Cr). A commercial milk 
replacer with a guaranteed analysis of 22% CP and 15% fat (Nurstrate®, Moorman’s, Inc., 
Quincy, IL ) was used for the BF replacer, whereas the HF replacer was formulated using 
85% o f  Nurstrate® and 15% Super calf-kit® (Merrick’s, Inc., Middleton, WI), a 
commercial high-energy milk replacer supplement with a guaranteed analysis o f 7%CP and 
60% fat. The estimated daily nutrient consumption (based on guaranteed analysis) from the 
BF and HF replacers for a 36.3 kg calf at birth are presented in Table 4.1. Both replacers
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Table 4.1. Estimated daily nutrient consumption1 from the basal2 and high-fat3 
^ ^ ^ ^ ^ ^ ^ ^ m ill^ e£ la cer^ fb i^ ^ ^ je |^ ja lfa lj)ir tfr^ ^ ^ ^ ^ ^ ^ ^ ^ ^
Estimated
Milk Replacers
Basal Fat High Fat
Crude Protein, g/d 114.4 114.6(97.4, 17.2)4
Fat, g/d 78.0 126.2(107.3, 18.9)
Carbohydrate, g/d 327.6 339.2 (288.3, 50.9)
Total, g/d 520 580 (493, 87)
‘Based on guaranteed analysis.
Nurstrate®, Moorman’s, Inc, Quincy, IL.
385% Nurstrate plus 15% Super calf-kit®, Merrick’s, Inc, Middleton, WI.
4In parentheses are grams provided by Nurstrate and Super Calf-kit, respectively.
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were reconstituted to 15% DM using 40 ± 1 °C tap water and calves receiving the BF and 
HF replacers received 1.4% and 1.6%, respectively, o f replacer DM per kg o f BW. The HF 
replacer was formulated such that calves fed the HF replacer consumed about 60% more 
fat but similar amounts o f carbohydrate and protein as calves fed the BF replacer (Table 
4.1). The milk replacer was given in two equal feedings at 0800 and 1600 daily throughout 
the experiment. Chromium was provided as Cr nicotinate (13.7% Cr, LONZA, Inc., 
Fairlawn, NJ). On the 1 st 2 d o f the experiment (d 4 and 5 o f  age), Cr was included at 5 
ppm (DM basis) as a priming dose and for the remainder o f  the experiment Cr was included 
at 1 ppm (DM basis).
On the morning following collection o f the wk 2 blood samples, calves were offered 
a commercial calf starter with a guaranteed analysis o f at least 16% CP and 2% fat (Purina® 
commercial calf starter/grower (coarse) BVT 60; Purina Mills, Inc, St. Louis, MO). Starter 
intake was recorded and fresh feed offered at each feeding. When a calf consumed all o f  its 
starter between feedings, an additional 100 g o f starter was offered. Body weight (BW) 
measurements were also obtained at noon when calves were around 2 and 5 wk o f age.
Blood Sample Collection and Metabolic Challenges. At 1,2, 3, 4 and 5 wk o f age, 
blood was collected immediately before (prefeeding) the 1600 feeding by jugular 
venipuncture into 7-mL evacuated tubes containing potassium oxalate and sodium fluoride 
(Sherwood Medical, St. Louis, MO). Starter was not removed prior to collection o f 
prefeeding blood samples collected at 3, 4, and 5 wk o f age. When calves were around 2 
and 5 wk o f age, blood samples were also collected by venipuncture prior to and .5, 1, 2,
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3, and 4 h after the 1600 replacer feeding. Starter was removed at 1200 when blood 
samples were collected relative to the 1600 replacer feeding, when calves were 5 wk o f age.
Around 5 wk o f age, an IVGTT was conducted to measure the calves abilities to 
clear a glucose load and an epinephrine challenge was conducted to study the relative 
magnitude o f NEFA release and subsequent reincorporation into adipose tissue. The 
IVGTT was performed after an overnight fast (16 h). Average starter intake for the 3 d 
preceding and on the d immediately preceding the IVGTT were .71 and .42 kg, respectively. 
Calves were given their full daily allotment o f  milk replacer at the evening feeding following 
the challenges. At 0700, calves were fitted with 14-G jugular catheters (Quik-Cath®, 
Baxter Healthcare, Deerfield, EL) and were allowed at least 1 h o f rest prior to the IVGTT. 
The IVGTT consisted of infusing a glucose solution (500 mg/kg o f BW; 50% w/v solution 
in sterile saline) as a bolus dose over a 30- to 60-s interval. Prior to infusion of glucose, one 
blood sample was drawn (0 min) and then glucose was administered (1 mlVkg BW) i.v. 
through the catheter. Blood was then drawn at 10, 20, 30, 40, 50, 60, 90 and 120 min 
relative to the glucose infusion.
During the 2-h period between completion o f the IVGTT and the epinephrine 
challenge, the calves were only allowed access to water. The epinephrine challenge 
consisted of a bolus i.v. infusion o f epinephrine (2 y.g Epinephrine-HCl/kg BW). Two pre­
infusion blood samples were drawn (- 20 and 0 min) and then epinephrine administered (.02 
mL/kg BW) i.v. through the catheter. Blood samples were then drawn at 10, 20, 40, 60, 
80, 100 and 120 min relative to propionate infusion. To ensure that none of the infusion 
solutions remained in the catheter sheath, following infusion o f glucose or epinephrine-HCl,
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sterile saline (5 mL) was flushed through the catheter. Catheters were maintained with 6% 
sodium citrate in sterile saline.
Blood Analyses. Plasma was analyzed for glucose (Sigma Tech. Bull. #315, 1989), 
cholesterol (Sigma Tech. Bull. # 352, 1992), and triacylglycerol (Sigma Tech. Bull # 334, 
1995) spectrophotometrically using commercial kits (Sigma Chemical, St. Louis, Mo.). 
Plasma NEFA concentrations were determined using a commercial enzymatic procedure 
(NEFA-C Kit, ACS-ACOD Method; Wako Chemicals, USA, Richmond, VA). Plasma 
insulin was determined by RIA as described by Sticker et al. (1995) and plasma cortisol was 
determined by a commercial kit (Cortisol RIA Kit No. DSL-2000; Diagnostic Systems 
Laboratories Inc., Webster, TX.). Samples were assayed in duplicate and measurements 
resulting in errors greater than 5% were re-analyzed. The exception was that the 
measurement of blood triacylglycerol and NEFA from the epinephrine challenge were not 
replicated.
Statistical Methods and Calculations. Clearance rates and area under the response 
curve (AUC) for glucose and insulin were computed for each calf following the IVGTT 
(Kaneko, 1989). To further evaluate carbohydrate metabolism a computer modeling 
procedure which has been used to evaluate glucose effectiveness (SG) and insulin sensitivity 
(S;) in humans was also employed (Watanabe et al., 1995; Bergman, 1997). In general, SG 
is a measure o f insulin-independent glucose disappearance from the circulation, whereas S{ 
is a measure o f insulin-dependent glucose clearance. The computer model was originally 
developed to evaluate SG and Sf, among other variables, based on glucose and insulin 
concentrations obtained at specific intervals in response to an i.v. infusion o f glucose,
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followed by an infusion o f insulin that is also given at a specific time. We did not employ 
the full minimal model procedure, nonetheless, the model was able to provide an estimate 
o f Sj from the glucose and insulin concentrations obtained from the IVGTT. The validity 
the S} values obtained and degree o f  fit by the model was evaluated by J. C. Lovejoy 
(Lovejoy, personal communication).
Data for initial BW, ADG, starter intake, kinetic analysis o f  metabolite challenges 
and relative to feeding responses were analyzed by least-squares ANOVA and PROC GLM 
o f SAS (SAS®, 1989). The model was a factorial including Cr level, fat level, and Cr by fat 
level interaction. Data for prefeeding (weekly) and responses relative to milk feedings (2 
and 5 wk of age) for hormone and metabolite concentrations were analyzed as a split-plot. 
In the whole plot, Cr level, fat level, and Cr by fat level were tested against calf (Cr x fat 
level) means square. In the sub-plot, the effect o f  time and all interactions o f time with Cr 
and fat level were tested against the residual mean square. The PROC UNIVARIATE 
procedure o f SAS (SAS® 1989) was used to test for normality and a Shapiro-Wilks test 
value o f 0.1 was selected for rejection o f the null hypothesis. When normality was rejected, 
data transformation was used to achieve normality and transformed values analyzed. Means 
are reported in original units and all statistical analyses were conducted using the GLM 
procedures o f SAS (SAS® 1989).
Results and Discussion
Background. In preweaning, conventionally-fed Holstein calves consuming a 
commercial 15% fat milk replacer supplemented with chromium picolinate, we observed 
NEFA concentrations were reduced (DePew et al., 1995). Although none o f the indices
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used to evaluate whether Cr had influenced glucose tolerance and (or) insulin effectiveness 
were significant, our interpretation o f the results, as a whole, led us to believe that calves 
receiving supplemental Cr may have maintained insulin sensitivity longer (age). Kegley 
(1997a) and co-workers observed that supplementation of Cr to the diets o f intensively-fed 
Holstein calves consuming a 20% fat milk replacer had no influence on most o f  the indices 
used to evaluate whether Cr affected glucose tolerance and (or) insulin effectiveness. 
However, based on the glucose response, following an i.v. infusion of insulin, these 
investigators stated, “tissues from calves that were fed Cr might have been more sensitive 
to the insulin, or the insulin might have had a longer lasting effect in these calves”. Because 
our study showed reduced NEFA concentrations, and both o f the previously mentioned 
studies hinted toward insulin sensitivity being maintained longer in Cr-fed calves, we 
included dietary flit level as a second factor under the premise that calves fed the higher level 
o f fat would have greater circulating blood lipid concentrations and become more insulin 
insensitive at an earlier age. This would enable us to develop a clearer picture o f whether 
the hypolipidemic effects and improved glucose tolerance/insulin sensitivity effects, that 
have been attributed to the supplementation o f Cr in humans with non-insulin dependent 
diabetes, (Wallach, 1985; Mertz, 1993) would also cause similar metabolic changes in the 
conventionally-fed, pre-weaned dairy calf.
Performance. Other than minor, controllable bouts o f scours, calves were healthy 
throughout the experiment. The rates o f gain achieved by the calves in the current 
experiment were comparable with and, in most instances, better than other investigators 
have reported for calves of similar ages and when similar feeding regimes were employed
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(Doppenberg and Palmquist, 1991; Quigley et al., 1991; Quigley and Bernard, 1992; Kegley 
et al., 1997a). No dietary interactions (P > .10) were observed among any o f  the 
performance criteria; therefore, only treatment effects are reported (Table 4.2). Chromium 
supplementation did not affect (P > . 10) ADG, ADG:DMI, or starter intake during any o f 
the feeding periods analyzed; however, while calves were fed milk alone there was a 
tendency for ADG (P =. 16) and ADGrDMI (P = . 16) to be greater in Cr-fed compared to 
control-fed calves. In pre-weaned Holstein calves, similar responses were observed when 
Cr-picolinate was supplemented in the diet o f conventionally-fed calves (DePew et al.,
1995) and when CrCl3 or a Cr-nicotinic acid complex was supplemented in the diet o f 
intensively-fed calves (Kegley et al., 1997a). In young (6 to 8 wk of age) weaned calves, 
no difference in ADG over a 51-d period was observed between control-fed calves and 
calves fed a high-Cr yeast supplemented starter (Arthington et al., 1997). Studies including 
supplementation of various Cr compounds to the diets o f ruminating calves (Bunting et al., 
1994; Wright et al., 1994; Chang et al., 1995; Kegley and Spears, 1995; Mathison and 
Engstrom, 1995) and lambs (Fomea et al., 1994; Kitchalong et al., 1995; Forbes et al., 
1998) have also reported no effect on rate of gain, DMI, or feed efficiency.
In ruminants, the greatest potential for supplemental Cr to increase performance 
(i.e., growth and milk production) would seem to be in animals in which metabolic demand 
is high (i.e., transit/market, intensive handling, reintroduction with a new group o f animals, 
early lactation). Supplementation of various Cr compounds to the diets o f “market-transit” 
stressed feeder calves had no effect on growth performance in some studies (Wright et al., 
1994; Chang et al., 1995; Kegley and Spears, 1995; Mathison and Engstrom, 1995). In
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
65
Table 4.2. Effect o f chromium nicotinate (CrNIC) and fat level on body weight gain 
^^^^^nd^starteM ntak jeL n^g^^ean^^onven tionall^^E to lsteii^alves^^^^
Treatment Fat Level
Item Control CrNIC SEM
P-value2 for 
treatment Basal High SEM
P-value2 for 
fat level
a 17 17 16 18
Initial BW. kg 37.7 39.3 1.5 .48 38.3 38.6 1.5 .88
ADG, kg
week 0 to 23 .18 .23 .03 .16 .17 .23 .03 .10
week 2 to 54 .48 .50 .04 .63 .48 .50 .04 .60
week 0 to 5 .36 .39 .02 .28 .36 .40 .02 .26
ADG:DML
kg/d
week 0 to 2 .31 .40 .04 .16 .32 .38 .04 .32
week 2 to 5 .51 .50 .03 .85 .51 .50 .03 .77
week 0 to 5 .46 .48 .02 .63 .47 .47 .02 .94
Starter intake, 
kg ofDM/d5 .38 .42 .03 .37 .39 .40 .03 .85
'There were no (P > .10) dietary treatment interactions, 
^obability  of a greater F-value.
3Milk-fed only.
4Starter plus milk-fed.
5Week 2 to 5.
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contrast, others reported improvements in some growth performance criteria, although, in 
such cases, the effects were generally limited to the first few wk after the calves arrived 
(Chang and Mowat, 1992; Moonsie-Shageer and Mowat, 1993; Mowat et al., 1993; 
Mathison and Engstrom, 1995; Kegley et al., 1997b). Why Cr supplementation results in 
improved growth performance, in some but not other similarly conducted experiments, is 
a matter o f  speculation. However, an animal’s individual Cr status prior to receiving 
supplemental Cr, the bioavailability and biological activity o f Cr compounds supplemented, 
and stressor variables, are frequently suggested as contributing factors. An explanation for 
the “stressor” association appears to stem from studies in man and laboratory animals that 
showed that as demand and (or) intensity of the demand increases, the body responds by 
increasing its mobilization of stored Cr and, once mobilized, any Cr that is not used, is 
excreted (Anderson et al., 1993). The likelihood o f  observing an effect from Cr 
supplementation under such a situation may therefore be heightened, because there is greater 
potential for Cr body stores to become depleted faster than can be replenished by the Cr that 
is available in the base feed stuffs.
In the current experiment, a colostrometer was used to ensure that only high quality 
colostrum (> 70 mg o f immunoglobulins/mL) was fed, and care was taken to ensure it was 
fed at recommended levels and within the recommended time (Donovan, 1992; Morrill, 
1992). Although immunoglobulin concentrations were not measured in the calves, it 
appears that adequate immunoglobulin transfer was achieved and adequate nutrients were 
supplied to the calves, such that health problems were minimized. Speculatively, it is 
possible that, because only healthy calves were initially included in the current experiment,
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and because only minor, controllable bouts of scours were observed throughout the 
experiment, minimal demands (beyond normal growth requirements) were placed on this 
group o f  young calves. As a result, no significant improvements in growth performance 
were detectable. Whether Cr supplementation would provide greater benefit for calves 
raised under more commercial dairy farm settings needs to  be investigated as Heinrichs
(1994) and co-workers reported that 75.5% of dairy calves on US farms receive less than 
adequate amounts o f colostrum within the first 24-h of birth. In addition, this statement 
assumes that calves were fed an acceptable quality colostrum (minimum of 50 mg of 
immunoglobulins/mL; Scott and Fellah, 1983) that ensured that adequate levels o f 
immunoglobulins were received by each calf.
Fat level of the replacer did not affect (P > . 10) ADG, ADG.DML, or starter intake 
over the entire 5 wk experimental period or during the period after the calves were given 
access to starter. However, while calves were fed milk alone, ADG (P = . 10) was greater 
in calves fed the HF replacer compared with those fed the LF replacer. Wijayasinghe et al. 
(1984) reported that intensively-fed calves receiving high (30%) versus low-fat (3%) milk 
replacers gained weight at similar rates from 1 to 3 wk o f age; however, after the 3rd wk, 
calves receiving the high-fat milk replacer gained weight faster than calves receiving the 
low-fat milk replacer. Scibilia (1987) and co-workers reported that ADG increased linearly 
with fat level (10%, 17.5%, 25%) o f the o f the milk replacer during the first 3 wk o f life, 
although the response was more dramatic when calves were housed at temperatures below 
compared with within the zone o f  thermal neutrality.
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Weekly Changes in Plasma Metabolites and Hormones. Irrespective o f dietary 
treatments, from 1 to 5 wk of age, plasma concentrations for glucose and NEFA decreased 
(P = .001; Figures 4 .1 and 4.3) and plasma concentrations for triacylglycerol and cholesterol 
increased (P = 0001; Figures 4.4 and 4.5). Over this period, plasma insulin concentrations 
were more stable; although, there was a slight tendency ( P = .17; Figure 4.2) for an 
increase. For glucose, NEFA and insulin, these age related changes agree with a similarly 
conducted experiment from our lab (DePew et al., 1995). In addition, other researchers 
have also observed similar age related changes for all the aforementioned metabolites and 
hormones (Shannon and Lascelles, 1966; Doppenberg and Palmquist, 1991; Quigley, et al., 
1991; Quigley and Bernard, 1992; Kuehn et al., 1994; Hugi and Blum, 1997).
Except for cholesterol (see below), no three-way interactions (P > . 10) among Cr, 
fat level, and age were observed for the blood variables measured (Figures 4 .1, 4.2, 4.3, 4.4, 
4.5), and no interactions (P > .10) between Cr and fat level were observed for the blood 
variables when averaged across the 5 wk. In addition, few interactions o f Cr with age or 
fat with age were observed; therefore, sampling dates were combined and only the 
independent effects o f Cr and fat level, for the various blood variables, are shown (Table 
4.3).
At 1 wk o f  age, plasma insulin concentrations were similar for calves in all dietary 
treatment groups, however, by wk 2, and lasting through wk 5, a gradual divergence was 
observed with plasma concentrations tending to be lower for calves fed Cr-supplemented 
replacer compared with those fed control replacer (Cr x age trend; P = . 11; Figure 4.2). In
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Figure 4.1. Weekly concentrations o f  plasm a glucose. Calves were fed 
m ilk replacer that contained either 15% (basal) o r 22% (high) fat without 
(control) or with supplemental chromium nicotinate (CrNIC). Solid line 
=  basal fat; dash line = high fat; square =  control; circle = CrNIC.
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Figure 4.2. Weekly concentrations o f  plasm a insulin. Calves were fed 
m ilk replacer that contained either 15% (basal) or 22% (high) fat without 
(control) or with supplemental chromium nicotinate (CrNIC). Solid line 
=  basal fat; dash line = high fat; square =  control; circle =  CrNIC.
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Figure 4.3. W eekly concentrations o f  plasm a nonestenfied fatty acids. 
Calves were fed m ilk replacer that contained either 15% (basal) or 22% 
(high) fat without (control) or with supplemental chromium nicotinate 
(CrNIC). Solid line = basal fat; dash line = high fat; square = control; 
circle = CrNIC.
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Figure 4.4. W eekly concentrations o f  plasm a triacylglycerol. Calves were 
fed milk replacer that contained either 15% (basal) or 22% (high) fat 
without (control) or w ith supplemental chromium nicotinate (CrNIC). 
Solid line =  basal fat; dash line = high fat; square = control; circle = 
CrNIC.
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Figure 4.5. Weekly concentrations o f plasma cholesterol. Calves were 
fed milk replacer that contained either 15% (basal) or 22% (high) fat 
without (control) or with supplemental chromium nicotinate (CrNIC). 
Solid line = basal fat; dash line = high fat; square = control; circle = 
CrNIC.
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Table 4.3. Effect o f chromium nicotinate (CrNIC) and fat level on prefeeding plasma 
glucose, insulin, nonesterified fatty acids (NEFA), triacylglycerol (TG), and 
cholesterol concentrations in pre-weaned, conventionally-fed Holstein calves1*23.
Treatment Fat Level
Item Control CrNIC
P-value4 for 
treatment Basal High
P-value4 for 
fat level
n 17 17 16 18
Glucose,
mM
5.32 
(5.15, 5.49)5
5.40 
(5.24, 5.57)
.47 5.26 
(5.09, 5.43)
5.46
(5.30, 5.63)
.09
Insulin.
ng/ml6
.86
(.59, 1.17)
.66 
(.42, .94)
.30 .78 
(.52, 1.09)
.73 
(.48,1.02)
.78
NEFA
mM7
.11
(.10,.13)
.13
(.11,-14)
.10 .11 
(.09, .12)
.13 
(12,.15)
.01
TG.
mg/dl8
19.6 
(15.7,23.9)
17.8
(14.1,21.9)
.53 18.1 
(14.3,22.4)
19.3
(15.5,23.4)
.67
Cholesterol.
mM9
2.14
(1.92,2.38)
2.39 
(2.15,2.63)
.14 2.18 
(1.94,2.42)
2.35
(2.13,2.58)
.28
‘Mean of samples taken at 1 ,2 ,3 ,4 , and 5 weeks o f age.
2Irrespective o f  age there were no (P > . 10) dietary treatment interactions.
3There were no interactions with age (P >10) except for plasma NEFA (fat x age; P = 
.0001) and cholesterol (treatment x fat x age; P= .01) concentrations.
Probability of a greater F-value.
sWith the exception of glucose, all means are based on analysis of transformed data; 
consequently, the lower and upper 95% confidence limits for each mean are given in 
parentheses.
6For statistical analysis, plasma insulin concentrations were transformed by raising the 
original values to the .7 power.
P o r  statistical analysis, plasma NEFA concentrations were transformed by taking the natural 
log o f the original values.
*For statistical analysis, plasma triacylglycerol concentrations were transformed by raising 
the original values to the .5 power.
*For statistical analysis, plasma cholesterol concentrations were transformed by raising the 
original value to the .7 power.
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contrast, plasma glucose concentrations in the Cr-fed and control-fed calves declined at a 
similar rate from wk to wk (P = .99; Figure 4.1). The lack of a Cr treatment difference for 
plasma glucose coupled with the divergence in plasma insulin between Cr-fed and control- 
fed calves suggests that insulin sensitivity may have been maintained longer in Cr-fed calves. 
In mid-gestating sows fed diets supplemented with Cr-picolinate, no differences in plasma 
glucose concentrations were observed (Lindemann et al., 1995). However, they did observe 
lower insulin and insulin to glucose ratios in the Cr-fed compared with the control-fed sows 
and interpreted this as evidence that Cr supplementation improved insulin action. In the 
present experiment, no Cr or interaction of Cr by age effects (P > . 10; data not shown) were 
observed for plasma insulin to glucose ratio; however, when the ratios were averaged across 
the 5 wk, the ratio was numerically but not significantly smaller (. 14 vs. . 19; P = . 17; data 
not shown) for the Cr-fed calves compared with the control-fed calves. In agreement with 
our findings, Kegley et al. (1997a) reported that neither supplemental CrCl3 nor a Cr- 
nicotinic acid complex affected prefeeding plasma glucose concentrations in milk-fed 
Holstein calves when there were 28 or 56 d old. In the aforementioned study, insulin was 
not reported for d 28 or 56; however, when calves were 9 to 10 wk old, plasma insulin 
concentrations (6 h after the preceding meal) were lower in Cr-fed compared with control- 
fed calves; again, plasma glucose concentrations were unaffected. This observation tends 
to agree with the present experiment, such that, Cr did not induce any change in plasma 
glucose concentrations, but plasma insulin concentrations (8 to 10 h after the preceding 
meal) tended to be lower in Cr-fed compared with control-fed calves.
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The decline in plasma NEFA concentrations from wk to wk was similar between Cr- 
fed and control-fed calves (Cr x age; P = .51; Figure 4.3). Bunting et al. (1994) also 
reported supplementing Cr, as Cr picolinate, in the ration o f ruminating steers and heifers 
for a period of 8 wk, did not affect plasma NEFA concentrations (Bunting et al., 1994). In 
contrast, ruminating lambs, fed diets supplemented with Cr picolinate, had lower plasma 
NEFA concentrations at 2, 7, and 11 wk (Kitchalong et al., 1995) and 11 and 22 d (Forbes 
et al., 1998) after supplementation was initiated, compared with control-fed lambs. Studies 
with ruminant and nonruminant animals alike have typically observed that supplemental Cr 
tends to either reduce (Samsell and Spears, 1989; Ward et al., 1995 DePew et al., 1995; 
Kitchalong et al., 1995; Amoikon et al., 1995; Ward et al., 1997; Forbes et al., 1998) or 
have no effect on plasma NEFA concentrations (Bunting et al., 1994; Ward et al., 1995 
Besong et al., 1996; Yang et al., 1996; DePew et al., 1996). Therefore, observing that 
plasma NEFA concentrations (averaged across the five wk) were greater (P = . 10; Table 
4.3) in Cr-fed compared with control-fed calves was not expected.
Over the weekly sampling dates, plasma cholesterol concentrations in calves fed Cr- 
supplemented replacer did not differ (P = .93) from those o f calves fed control replacer; 
however, there was a Cr by fet by age effect (P = .01; Figure 4.5). This latter effect seemed 
more apparent while calves received only milk. In essence, calves fed the Cr-supplemented, 
HF replacer had higher plasma cholesterol concentrations compared with calves fed the 
control, HF replacer, whereas, calves fed the Cr-supplemented, BF replacer had lower 
plasma cholesterol concentrations compared with calves fed the control, BF replacer. The 
cholesterol-lowering ability o f organic Cr complexes has been shown in both monogastrics
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(Mertz, 1993; Page et al., 1993), and ruminants (Bunting et al., 1994; Kitchalong et al.,
1995), but again this response is not always observed (Ward et al., 1997; Forbes et al., 
1998). Kegley et al. (1997a) reported that supplementing Cr as either CrCl3 or a Cr- 
nicotinic acid complex in the milk replacer fed to milk-only-fed calves did not affect 
postfeeding (3 h) serum cholesterol concentrations at any time during the initial 9 to 10 wk 
o f life.
Neither Cr nor Cr by age effects (P > .10; Figure 4.4) were observed for plasma 
triacylglycerol concentrations. Similar observations have been reported in lambs 
(Kitchalong et al., 1995; Forbes et al., 1998) and pigs (Lindemann et al., 1995). To our 
knowledge, supplementing Cr to livestock has not been observed to affect plasma 
triacylglycerol concentrations. However, when Holstein cows were fed Cr-picolinate, 
beginning 30 d prepartum, it has been reported that liver triacylglycerol levels (d 30 o f 
lactation) were lower in the Cr-fed compared with the control-fed cows (Besong et al.,
1996). In men classified as being either ketosis-prone; ketosis-resistant, nonobese; and 
ketosis-resistant, obese, Rabinowitz et al. (1983) reported no change in serum 
triacylglycerol concentrations following 4 mo o f  Cr supplementation as CrCl3, a Brewer’s 
yeast that contained Cr as GTF, or a Brewer’s yeast extract without GTF. By contrast, 
Abraham et al. (1992) reported that supplemental Cr, as CrCl3, for a period o f 7 to 16 mo 
lowered serum triacylglycerol concentrations. In non-insulin-dependent diabetes mellitus 
patients, Lee and Reasner (1994) also reported that triacylglycerol concentrations were 
significantly reduced following 2 months o f Cr supplementation as Cr picolinate.
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No interactions between fat level and age were observed for plasma insulin, 
triacylglycerol, and cholesterol concentrations (P > . 10; Table 4.3). No interaction between 
fat level and age was also observed for plasma glucose concentrations (P = .59; Figure 4.1); 
however, when concentrations were averaged across wk, calves fed HF replacer had greater 
(P = .09; Table 4.3) plasma glucose concentrations compared with calves fed BF replacer. 
Figure 4.1 shows that the divergence in glucose levels between calves fed HF and LF milk 
replacers did not begin to occur until 3 wk of age. In humans fed diets considered moderate 
in dietary fat (30 - 40% of dietary energy from fat), it has been shown that insulin sensitivity 
begins to decrease and hyperglycemia begins to develop at around the second to third wk 
after the dietary regimen begins (Fukagawa et al., 1990; Swinbum et al., 1991). Feeding 
o f a diet where 60% o f the energy is provided by fat has been shown to reduce insulin 
sensitivity within days after the dietary regimen is begun (Sidery et al., 1990). In rats, 
insulin sensitivity has also been shown to increase within wk after reducing dietary fat from 
40 to 30% of dietary energy (Harris and Kor, 1992). In intensively-fed calves, Wijayasinghe 
et al. (1984) reported that plasma glucose concentrations were greater in calves receiving 
milk replacer containing higher levels o f fat. Although the difference in fat levels fed in the 
Wijayasinghe study were more extreme (3 vs. 30%), they suggested that the greater dietary 
availability o f glucose in the lower-fat, higher-carbohydrate-fed calves may have caused 
greater release of insulin, and this in turn resulted in maintenance o f lower steady state 
plasma glucose concentrations.
To our knowledge, this is the first study to report on the effects o f  Cr 
supplementation in livestock fed diets with added fat. At 1 wk o f age, plasma NEFA
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concentrations were lower in calves fed HF replacer than in calves fed BF replacer, 
however, from wk 2 though 5 o f  age, plasma NEFA concentrations were greater in calves 
fed HF replacer compared with those fed BF (fat x age; P= .0001; Figure 4.3). Jaster et al. 
(1992) reported no effect o f  added fat (113 and 226 g) on plasma NEFA concentrations in 
calves fed only milk during the first 6 wk o f life. In humans, increases in blood lipids have 
commonly been observed to be linearly correlated with dietary fat intakes (Harris and Jones, 
1991).
Changes in Plasma Metabolites and Hormones in Response to a Milk Feeding Before 
Calves had Access to Starter. Changes over time and selected response variables 
(prefeeding concentrations, peak concentrations, and area under the curve) for plasma 
glucose, insulin, NEFA, and triacylglycerol from samples taken relative to a milk feeding, 
before calves had access to starter, are presented in Figures 4.6 through 4.9, and Table 4.4, 
respectively. No Cr by time effect (P = .21; Figure 4.6) was observed for plasma glucose; 
however, prefeeding and peak postfeeding plasma glucose concentrations were greater ( P 
< 0 1 ;  Table 4.4) in the Cr-fed compared with the control-fed calves. In calves fed only 
milk, Kegley et al. (1997a) also showed that Cr supplementation (as CrCl3 or a Cr-nicotinic 
acid complex) had no effect on pre- or postfeeding (1 h) plasma glucose concentrations 
taken at various times during the first nine wk of life. In addition, plasma glucose 
concentrations relative to a milk feeding, when calves were 9 to 10 wk old, did not differ 
between Cr-fed compared with control-fed calves. In weaned lambs, Kitchalong et al. 
(1995) also reported that supplemental Cr, as Cr picolinate, did not affect pre- and 
postfeeding (3 h) plasma glucose concentrations at wk 2, 7, and 11 after supplementation
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Figure 4.6. Changes in plasm a glucose concentrations relative to a milk 
feeding at 2 weeks o f  age. Calves were fed m ilk replacer that contained 
either 15% (basal) or 22% (high) fat without (control) or with 
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash 
line = high fat; square = control; circle =  CrNIC.
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Figure 4.7. Changes in plasm a insulin concentrations relative to a  milk 
feeding at 2 weeks o f  age. Calves were fed m ilk replacer that contained 
either 15% (basal) or 22% (high) fat without (control) or with 
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash 
line =  high fat; square =  control; circle = CrNIC.
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Figure 4.8. Changes in plasm a nonesterified fatty acid (NEFA) 
concentrations relative to a  milk feeding at 2 weeks o f age. Calves were 
fed milk replacer that contained either 15% (basal) or 22% (high) fat 
without (control) or with supplemental chromium nicotinate (CrNIC). 
Solid line = basal fat; dash line = high fat; square = control; circle = 
CrNIC.
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Figure 4.9. Changes in plasm a triacylglycerol concentrations relative to a 
milk feeding at 2 weeks o f  age. Calves were fed milk replacer that 
contained either 15% (basal) or 22% (high) fat without (control) or with 
supplemental chromium nicotinate (CrNIC). Solid line -  basal fat; dash 
line = high fat; square =  control; circle = CrNIC.
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Table 4.4. Effect o f chromium nicotinate (CrNIC) and fat level on 
plasma glucose, insulin, nonesterified fatty acids (NEFA) and triacylglycerol 
responses relative to consumption o f  milk replacer in 2 week old pre-weaned, 
_________________ conventionally-fed Holstein calves1.__________________
Treatment Fat Level
P-value2 P-value2
Item for for
Control CrNIC SEM Treatment Basal High SEM Fat Level
n 17 17 16 18
Glucose
Basal concentration,
mM3
5.2 5.8 .12 .004 5.4 5.5 .12 .46
Peak concentration, 
mM4 6.7 7.5 .20 .01 7.3 6.9 .20 .11
Response curve 
area,h-mM5 3.3 2.6 .54 .40 3.5 2.4 .54 .17
In su lin
Basal concentration, 
nj^ ml
.98 .94 .15 .88 .92 1.0 .15 .72
Peak concentration, 
ngtal
2.4 2.4 .39 .97 2.4 2.4 .39 .99
ftapense curve 
area.h-ng/ml
3.0 2.7 .52 .63 2.9 2.8 .52 .86
NEFA
Basal concentration, 
mM
.17 .17 .02 .89 .17 .18 .01 .57
Peak concentration. 
mM
.28 .28 .02 .93 .27 .29 .02 .60
Re^xnse curve 
area, hmM
.20 .16 .05 .65 .17 .19 .05 .59
Triacylglycerol
Basal concentration, 
mM
24.4 19.3 3.4 .30 19.5 24.2 3.4 .34
Peak concentration, 
mM
45.5 38.3 4.5 .27 40.7 43.1 4.5 .70
Response curve 
area, hmM
28.2 38.4 9.0 .43 38.2 28.4 9.0 .45
(Table con’d)
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‘There were no ( P > . 10) dietary treatment interactions, except for NEFA area under the 
response curve (treatment x fat; P = .002).
Probability o f a greater F-value.
3Basal concentrations = one sample taken immediately prior to offering milk.
4Highest point following consumption o f milk.
5Response curve area = area-under the response curve relative to basal levels computed 
using trapezoidal geometry for the time period 0 to 4 h after offering milk.
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was begun. Prefeeding plasma glucose concentrations did not differ (P = .46; Table 4.4) 
between HF-fed and BF-fed calves and no fat by time interaction (P = .53; Figure 4.6) was 
observed; however, for plasma glucose there was a tendency (P = . 11; Table 4.4) for peak 
concentrations to be greater for calves fed BF replacer compared with those fed the HF 
replacer. In pre-weaned dairy calves fed milk replacer containing either 5% or 25% fat, no 
differences were observed in plasma glucose concentrations 1 h after the calves had 
consumed their respective milk replacers (Bazin and Brisson, 1976). During the milk 
feeding at 2 wk o f age, none o f the response variables (prefeeding concentration, peak 
concentration height, and AUC; Table 4.4) and no dietary treatment by time effects (P > 
. 10; Figure 4.7) were observed for plasma insulin concentrations. In milk only fed calves, 
Kegley et al. (1997a) also showed that Cr supplementation, as CrCl3 or a Cr-nicotinic acid 
complex, had no effect on prefeeding plasma insulin concentrations or changes in plasma 
insulin concentrations when milk replacer was fed. Prefeeding plasma NEFA concentrations 
were not different (P > .10; Table 4.4) between dietary treatments; however, a Cr by fat by 
time interaction (P = .0001; Figure 4.8) was observed in response to the feeding such that, 
NEFA concentrations increased in CrNIC, HF-fed calves compared with control, HF-fed 
calves and decreased in CrNIC, BF-fed calves compared with control, BF-fed calves. As 
observed in Table 4.4, the AUC (P = .0002) and peak concentrations (P = .17) also showed 
that the level o f dietary fat influenced how plasma NEFA responded in the Cr-fed compared 
with the control-fed calves. Following the milk feeding at 2 wk of age, none of the response 
variables (prefeeding concentration, peak concentration height, and AUC; Table 4.4) for 
plasma triacylglycerol were affected by dietary treatments; however, in response to the milk
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feeding, plasma triacylglycerol concentrations did not increase (Cr x time; P = .02; Figure 
4.9) as much in the Cr-fed as in the control-fed calves.
Changes in Plasma Metabolites and Hormones in Response to a Milk Feeding After 
Calves had Access to Starter. Changes over time and selected response variables for 
glucose, insulin, NEFA, and triacylglycerol from samples, taken relative to a milk feeding 
after calves had access to starter for 3 wk, are presented in Figures 4.10 through 4.13, and 
Table 4.5. No Cr by time effects (P > . 10; Figures 4.10, 4.11,4.12, 4.13) were observed 
and Cr supplementation alone did not affect (P > .10; Table 4.5) prefeeding, peak 
postfeeding, or AUC for any o f  the metabolites or hormones. A fat by time interaction (P 
= 68; Figure 4.10) was not observed for plasma glucose; however, prefeeding plasma 
glucose concentrations tended to be greater (P = .13; Table 4.5) and peak postfeeding 
plasma glucose concentrations were greater (P = .02; Table 4.5) in the HF-fed compared 
to the BF-fed calves. For plasma insulin, a fat by time interaction (P = .02; Figure 4.11) was 
observed such that concentrations increased more in the HF-fed calves during the initial h 
after feeding compared with the BF-fed calves. When calves were fed the BF milk replacer, 
prefeeding plasma insulin concentrations were higher in calves receiving supplemental Cr 
compared with those fed the control; whereas, when calves were fed the HF milk replacer, 
prefeeding plasma insulin concentrations were lower in calves receiving supplemental Cr 
compared with those fed the control (P = . 10. Cr x fat trend; Figure 4.11). For plasma 
NEFA, a Cr by fat by time interaction (P = .03; Figure 4.12) was observed such that, in the 
calves fed the BF replacer, less o f a rise in plasma NEFA concentration was observed in the 
Cr-fed compared with the control-fed calves; whereas, in the calves fed the HF replacer,
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Figure 4.10. Changes in plasm a glucose concentrations relative to a m ilk 
feeding at 5 weeks o f  age. Calves were fed milk replacer that contained 
either 15% (basal) or 22%  (high) fat without (control) or with 
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash 
line = high fat; square =  control; circle = CrNIC.
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Figure 4.11. Changes in plasm a insulin concentrations relative to a m ilk 
feeding at 5 weeks o f  age. Calves were fed milk replacer that contained  
either 15% (basal) or 22%  (high) fat without (control) or with 
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash 
line = high fat; square = control; circle = CrNIC.
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Figure 4.12. Changes in plasma nonesterified fatty acid (NEFA) 
concentrations relative to a milk feeding at 5 weeks o f age. Calves were 
fed milk replacer that contained either 15% (basal) or 22% (high) fat 
without (control) or with supplemental chromium nicotinate (CrNIC). 
Solid line = basal fat; dash line = high fat; square = control; circle = 
CrNIC.
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Figure 4.13. Change in plasma triacylglycerol concentrations relative to a 
milk feeding at 5 weeks o f  age. Calves were fed milk replacer that 
contained either 15% (basal) or 22% (high) fat without (control) or with 
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash 
line = high fat; square = control; circle =  CrNIC.
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Table 4.5. Effect o f  chromium nicotinate (CrNIC) and fat level on 
plasma glucose, insulin, nonesterified fatty acids (NEFA) and triacylglycerol 
responses relative to consumption o f milk replacer in 5 week old pre-weaned, 
_________________ conventionally-fed Holstein calves1.__________________
Treatment Fat Level
Item Control CrNIC SEM
P-value2
for
Treatment Basal High SEM
P-value3 
for 
Fat Level
n 17 17 16 18
Glucose
Basal concentration,
mM3
5.0 5.0 .15 .79 4.8 5.2 .15 .13
Peak concentration, 
mM4 6.5 6.6 .18 .90 6.3 6.9 .18 .02
Response curve 
area, h-mM5 2.9 4.0 .53 .17 3.3 3.5 .53 .81
Insulin
Basal concentration, 
ng'ml
1.1 .92 .20 .46 1.0 1.0 .20 .83
Peak concentration, 
ng/ml
3.1 3.5 .55 .63 2.9 3.7 .55 .29
Response curve 
area, h-ng/ml
2.6 5.0 1.20 .28 3.1 4.4 1.16 .97
NEFA
Basal concentration, 
mM
.12 .15 .02 .36 .11 .16 .02 .06
Peak concentration, 
mM
.23 .27 .02 .14 .21 .29 .02 .008
Response curve 
area, h-mM
.20 .19 .05 .87 .16 .22 .05 .40
Triacylglycerol
Basal concentration, 
mM
32.7 27.9 3.2 .29 27.7 33.0 3.1 .25
Peak concentration, 
mM
52.6 49.1 3.3 .46 48.1 53.7 3.3 .25
Response curve 
area, h-mM
32.3 40.1 8.4 .51 36.7 35.6 8.4 .93
(Table con’d)
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'There were no ( P > .10) dietary treatment interactions, except for prefeeding plasma 
insulin (treatment x fat; P = . 10) and peak plasma NEFA concentrations (treatment x fat; 
P = .004).
Probability of a greater F-value.
3Basal concentrations = one sample immediately prior to offering milk.
4Highest point following consumption o f milk.
5Response curve area = area-under the response curve relative to basal levels computed 
using trapezoidal geometry fro the time period 0 to 4 h after offering milk.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
88
the rise in plasma NEFA concentration was much more dramatic in the Cr-fed compared 
with the control-fed calves. Prefeeding plasma NEFA concentrations were greater (P = .06; 
Table 4.5) for calves fed HF replacer compared with the calves fed the LF replacer. When 
calves were fed the BF milk replacer, peak postfeeding plasma NEFA concentrations were 
lower in calves receiving the Cr-supplemented replacer compared with calves receiving the 
control replacer, whereas, when calves were fed the HF milk replacer, peak postfeeding 
plasma NEFA concentrations were higher in calves receiving the Cr-supplemented replacer 
compared with the calves receiving the control replacer (P = .004; Table 4.5). Area under 
the response curve for plasma NEFA was not affected (P > . 10; Table 4.5) by treatment. 
For triacylglycerol, there were no fat by time interactions (P = .96; Figure 4.13) and none 
o f the response variables were affected by the fat level o f  the milk replacer (P > .10; Table 
4.5).
Changes in Plasma Metabolites and Hormones During an Intravenous Glucose 
Tolerance Test. The changes over time and selected response variables (pre-injections 
concentrations, clearance rates, and area under the curve) for glucose and insulin during the 
IVGTT are presented in Figures 4.14 and 4.15 and Table 4.6, respectively. Pre-injection 
plasma glucose and insulin concentrations were similar for the dietary treatments (P > . 10; 
Table 4.6), and no independent dietary treatment by time interactions (P > . 10; Figures 4.14 
and 4.15) were observed. The Cr by fat by time three-way interactions for glucose (P = .13) 
and insulin (P = . 19) were also not significant. However, both metabolites responded in a 
similar manner. When the area under the glucose response curves were calculated from 0 
to 60 and from 0 to 120 min post-injection, no dietary treatment differences were observed
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Figure 4.14. Changes in plasma glucose concentrations during an i.v. 
glucose tolerance test conducted at 5 weeks o f  age. Calves were fed milk 
replacer that contained either 15% (basal) o r 22% (high) fat without 
(control) or with supplemental chromium nicotinate (CrNIC). Solid line 
=  basal fat; dash line = high fat; square =  control; circle = CrNIC.
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Figure 4.15. Changes in plasma insulin concentrations during an i.v. 
glucose tolerance test conducted at 5 weeks o f  age. Calves were fed milk 
replacer that contained either 15% (basal) or 22% (high) fat without 
(control) or with supplemental chromium nicotinate (CrNIC). Solid line 
= basal fat; dash line = high fat; square = control; circle = CrNIC.
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Table 4.6. Effect of chromium nicotinate (CrNIC) and fat level on kinetic response variables1 during an i.v. glucose tolerance test in 
______________________________5 week old pre-weaned, conventionally-fed Holstein calves2.______________________________
Treatment Fat Level
Item Control CrNIC SEM
P-value3 for 
treatment Basal High SEM
P-value3 for 
treatment
n 17 17 16 18
Glucose Kinetics
Basal concentrations, mM 4.2 4.2 .10 .73 4.1 4.2 .10 .37
Clearance rate, %/min4 1.10 ( 89, 1.24)5 1.01 (.81,1.24) .57 1.15 ( 93, 1.40) .97 (.77,1.18) .24
Response curve area, min-mM 
Post-challenge interval
0 to 60 min 345 344 10.4 .93 345 344 10.5 .94
0 to 120 min 431 426 26.2 .90 424 433 26.0 .80
Insulin Kinetics
Basal concentrations, ng/ml .79 .81 .09 .84 .83 .76 .08 .57
Clearance rate, %/min .95 1.20 .55 .74 1.20 .95 .55 .75
Response curve area, min'ng/ml 
Post-challenge interval
0 to 60 min6 91(68,124) 78(58,106) .45 74(34,101) 97 (72,130) .20
0 to 120 min6 140(108,182) 112(87, 146) .22 106(81, 138) 149(116, 192) .07
Insulin Sensitivity Index7 2.45 (1.59,3.30) 3.76(2.63, 3 09) .09 4.08(2.87, 3.30) 2.21 (1.14,3.18) .02
(Table con’dj 
o
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‘Kinetic criteria: basal concentrations immediately prior to challenges; clearance rate computed from 20 to SO min after glucose challenge. 
2There were no (P > . 10) dietary treatment interactions.
Probability of a greater F-value.
4For statistical analysis, glucose clearance rates were transformed by raising the original values to the .5 power.
*For glucose clearance rate, insulin response curve area, and insulin sensitivity index, all means are based on analysis o f transformed data; 
consequently, the lower and upper 95% confidence limits for each mean are given in parentheses.
6For statistical analysis, insulin response curve areas were transformed by taking the natural log of the original values.
7Based on a computer model (Bergman, 1997): larger number indicates = more insulin sensitive: Insulin sensitivity indexes were transformed 
by raising the original values to the .5 power.
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(P > . 10; Table 4.6). During the initial h post-injection (0 to 60 min), insulin AUC was also 
not affected (P > . 10) by dietary treatments; however, over the 2-h sampling period (0 to 
120 min), area under the insulin response curve was greater (P = .07) in calves fed the HF 
replacer compared with those fed the BF replacer. Similar responses have been observed in 
milk-fed calves (Kegley et al., 1997a) and in ruminating lambs (Fomea et al., 1994; 
Kitchalong et al., 1995; Forbes et al., 1998) and calves (Bunting et al., 1994).
Glucose and (or) insulin clearance rates following an IVGTT or an IV1CT have been 
the primary diagnostic tool used to evaluate whether supplemental Cr affected glucose 
tolerance/insulin sensitivity. In the current experiment, glucose and insulin clearance rates 
were not affected (P > . 10; Table 4.6) by the dietary treatments. Kegley et al. (1997a) also 
reported that supplemental Cr had no effect on glucose clearance rate following an IVGTT 
conducted in 9 to 10-wk old intensively-fed calves. Fomea et al. (1994), Kitchalong et al. 
(1995), and Forbes et al. (1998) have also reported no effect o f supplemental Cr-picolinate 
on glucose clearance rates in lambs administered an IVGTT. Bunting et al. (1994) reported 
supplemental Cr (as Cr-picolinate) increased glucose clearance rates by 40% in steers and 
by 27% in heifer calves during an IVGTT. It is noteworthy that the clearance rates were 
faster for the older, milk-fed calves (fed a 20% fat milk replacer was fed) used by Kegley 
et al. (1997a) compared to the younger, conventionally-fed calves (fed on average a 19% 
fat milk replacer) used in the current experiment (average o f all treatments = 1.59 vs 1.06 
%/min, respectively).
As mentioned in the material and methods, the plasma glucose and insulin 
concentrations obtained from the IVGTT were also evaluated by a computer modeling
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procedure that allowed us to obtain an index o f insulin-dependent glucose clearance (insulin 
sensitivity index). A higher index value indicates that the subject is more insulin sensitive. 
The insulin sensitivity index values obtained were similar to those that have been reported 
for non-insulin dependent diabetic human subjects (Watanabe et al., 1995) and for humans 
fed a low fat compared to a high fat diet (Lovejoy, unpublished). More classical methods, 
such as the pancreatic suppression test and glucose clamps, have been compared to the 
minimal model approach. All methods used have shown that insulin sensitivity decreases 
as the level o f dietary fat in the diet increases (Sidery et al., 1990; Harris and Kor, 1992). 
For the current experiment, both Cr level and dietary fat level had independent effects on 
the insulin sensitivity index. Calves fed the Cr-supplemented replacer had higher (P = .09) 
index values than calves fed the control replacer (3.76 vs 2.45, respectively) and calves fed 
the BF replacer had higher (P = .02) index values than calves fed the HF replacer (4.08 vs. 
2.21, respectively). The fat effect supports our original hypothesis that feeding calves a 
higher level o f dietary fat would have reduced insulin sensitivity. This Cr effect is similar 
to that o f Kegley et al. (1997a) where they suggested that Cr supplementation may prolong 
insulin sensitivity prior to the time calves are weaned.
Changes in Plasma Metabolites and Hormones During an Epinephrine Challenge. 
Changes plasma concentrations over time and selected response variables (pre-injection 
concentrations and area under the curve) for glucose, NEFA, and triacylglycerol during the 
epinephrine challenge are represented in Figures 4.16 through 4.18, and Table 4.7. Pre­
injection plasma glucose, NEFA, and triacylglycerol concentrations did not differ between 
treatments (P > . 10; Table 4.7); however, there was a tendency for plasma triacylglycerol
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
94
concentrations to be greater (P = .11; Table 4.7) in calves fed the HF-replacer compared 
with calves fed the LF-replacer. Plasma glucose, NEFA, and triacylglycerol concentrations 
all peaked within 10 min after the epinephrine was given (P = 0001). Plasma glucose and 
NEFA concentrations returned to pre-injection levels by around 60 min and remained stable 
over the ensuing h. For all dietary treatments, a similar pattern was observed for plasma 
triacylglycerol concentrations throughout the first 40 min post-injection; however, after 
plasma triacylglycerol concentrations reached their lowest post-injection point, 
concentrations began to increase in the control-fed calves but remained relative stable in the 
Cr-fed calves. The triacylglycerol area under the curve from 0 to  60 min did not differ (P 
= .22) between Cr-fed and control-fed calves; but, over the entire 120 min sampling period, 
there was a slight tendency (P = .15) for area under the curve to be lower in Cr-fed 
compared with the control-fed calves (234 vs 506, respectively). Because epinephrine is a 
potent catecholamine (Brockman and Laarveld, 1986) and catecholamines have been shown 
to stimulate glycogenolysis, gluconeogenesis, and lipolysis in ruminants and nonruminants 
(Blum et al., 1982; Mersmann, 1989; Chapa et al., 1996), the rise in glucose, NEFA, and 
triacylglycerol was expected. Based on the current findings, it is possible that Cr helps to 
stabilize plasma lipid concentrations.
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Figure 4.16. Changes in plasma glucose concentrations relative to an 
epinephrine infusion at 5 weeks o f  age. Calves were fed milk replacer that 
contained either 15% (basal) or 22% (high) fat without (control) or with 
supplemental chromium nicotinate (CrNIC). Solid line = basal fat; dash 
line = high fat; square = control; circle =  CrNIC.
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Figure 4.17. Changes in plasma nonesterified fat acid (NEFA) 
concentrations relative to an epinephrine infusion at 5 weeks o f  age. 
Calves were fed milk replacer that contained either 15% (basal) or 22% 
(high) fat without (control) or with supplemental chromium nicotinate 
(CrNIC). Solid line =  basal fat; dash line =  high fat; square =control; 
circle =  CrNIC.
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Figure 4.18. Changes in  plasma triacylglycerol concentrations relative to 
an epinephrine infusion at 5 weeks o f  age. Calves were fed milk replacer 
that contained either 15% (basal) o r 22% (high) fat without (control) or 
w ith supplemental chromium nicotinate (CrNIC). Solid line =  basal fat; 
dash line = high fat; square = control; circle =  CrNIC.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Reproduced 
with 
perm
ission 
of the 
copyright ow
ner. 
Further reproduction 
prohibited 
w
ithout perm
ission.
Table 4.7. Effect of chromium nicotinate (CrNIC) and fat level on kinetic response variables' during an i.v. epinephrine infusion in 5
Treatment Fat Level
Item Control CrNIC
P-value3 for 
SEM treatment Basal High SEM
P-value3 for 
Fat Level
Glucose Kinetics 
Basal concentration, mM
Response Curve area, min-mM 
Post-challenge interval 
0 to 60 min4 
0 to 120 min4
NEFA Kinetics
Basal concentration, mM
Response Curve area, mM-min 
Post-challenge interval 
0 to 60 min4 
0 to 120 min
Triacylglycerol Kinetics
Basal concentration, mg/dl
Response Curve area, mM-min 
Post-challenge interval 
0 to 60 min 
0 to 120 min
17
3.49
2 5 .3 ( 16.5, 36.2)’ 
4 2 .8 (22.1, 68.7)
.78
7.7 (3 .0 . 13.6 ) 
16.6
19.0
256
506
17
3.58
16.6(9.5, 25.4) 
30.7(12.7,53.7)
.83
9.3 (4 .2 , 15.4 ) 
17.0
18.7
163
234
.13
.06
5.5
2.0
53.2
129.9
.66
.16
.43
.61
.69
.96
.91
.22
.15
16
3.46
18
3.62
15.3(8.4,24.2) 26.9(18.0,37.7)
27.7(9.9,50.7) 46.3(25.4,72.1)
.79
10.0(4.7,16.5) 
19.5
16.5
217
390
.82
7.1 (2.6,12.6) 
14.0
21.2
303
349
.13
.06
5.5
2.0
53.3
128.8
.40
.07
.23
.81
.44
.48
. 1 1
.86
.82
(Table con’d)
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'Kinetic criteria: basal concentrations are average of 2 samples taken 10 min and immediately prior to challenge.
2There were no (P > . 10) dietary treatment interactions.
Probability of a greater F-value.
4For statistical analysis, glucose (0 to 60 and 0 to 120 min) and insulin (0 to 60 min) response curve areas were transformed by raising the 
original values to the .4 power.
*For glucose (0 to 60 and 0 to 120 min) and insulin (0 to 60 min) response curve areas, all means are based on analysis of transformed data; 
consequently, the lower and upper 9S% confidence limits for each mean are given in parentheses.
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CHAPTER V 
OVERALL SUMMARY AND CONCLUSIONS 
Two experiments were conducted to determine the effects o f supplemental 
chromium (Cr; 1 ppm), as chromium picolinate (CrP; exp. 1) or chromium nicotinate 
(CrNIC; exp. 2), on performance, glucose metabolism, and lipid metabolism of 
conventionally-fed Holstein calves.
Supplemental CrP (Exp. 1; between birth and 2 to 3 wk post-weaning) was observed 
to increase ADG in bull calves but to decrease ADG in heifer calves. Additionally, modest 
increases in ADG (Exp. 2) were observed while calves were fed milk alone. From these 
experiments, it was concluded that performance benefits alone will not justify usage of 
supplemental Cr in conventionally-reared dairy calves.
In cattle, research efforts have identified two situations in which Cr supplementation 
might have a commercial application: newly arrived feedlot cattle and first-lactation dairy 
cattle during the transition period. In swine, research has determined, that under some 
situations, Cr supplementation might favorably alter metabolism with resultant 
improvements in performance. Overall, it appears that supplemental Cr tends to improve 
performance in situations in which demands (nutritional, metabolic, environmental, etc.) 
placed on the animal are high. It is possible that the effects o f Cr on performance were 
minimal in our experiments, because the demands imposed on the calves were reduced 
through optimum calf management and husbandry practices. For instance, in the current 
experiments, care was taken to ensure that adequate amounts o f high quality colostrum was 
provided to all calves in a timely manner. Additionally, only calves readily drinking from
99
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buckets and not displaying any apparent health problems were included in the current 
experiment. These are probably the primary reasons that the incidence and severity o f  calf 
scours were low and that the rates of gain tended to exceed those reported for calves of 
similar ages, and when similar feeding regimes were employed. Heinrichs et al. (1994) 
reported that 25.6% and 75.5% o f calves on US farms receive less than 1.9 L and less than 
3.8 L of colostrum within the first 24 h o f life, respectively. Even when an acceptable 
quality o f colostrum (> 50 mg o f  immunoglobulins/mL o f colostrum; Scott and Fellah, 
1983) is used it has been determined that calves receiving less than 1.9 L of this colostrum 
will not receive an adequate level o f  immunoglobulins (Scott et al., 1981). Calves receiving 
between 1.9 and 3.8 L also may not receive adequate immunoglobulins (Heinrichs et al., 
1994). Whether Cr supplementation would have greater effects on performance (gain, 
health) in dairy calves, raised under less than ideal calf management practices, warrants 
investigation.
From Exp. 1 and 2, it was concluded that supplemental Cr had limited and (or) 
inconsistent effects on the metabolites and hormones measured before (prefeeding) and after 
milk feedings. Supplemental CrP did not affect prefeeding plasma glucose, insulin, cortisol, 
or IGF-1 concentrations and did not affect the postfeeding rise in plasma glucose or insulin 
concentrations. Supplemental CrNIC did not affect prefeeding plasma glucose, insulin, 
triacylglycerol, or cholesterol concentrations, although there was a tendency for CrNIC to 
lower prefeeding plasma insulin concentrations. Regarding NEFA, supplemental CrP 
lowered pre- and postfeeding plasma NEFA concentrations in Exp. 1, whereas in Exp. 2, 
prefeeding plasma NEFA concentrations w oe greater when CrNIC was supplemented. This
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latter effect was largely because plasma NEFA concentrations in the calves fed the CrNIC, 
high fat-replacer did not decrease with age to the extent observed for the other treatment 
groups. From Exp. 2, basal cholesterol and triacylglycerol (under some situations) also 
tended to show that fat level of the diet affected how these metabolites responded to 
supplemental Cr. In response to milk feedings (Exp. 2 only), CrNIC and fat level had only 
small effects on the blood metabolites measured; however, the findings did suggest that fat 
level o f the diet needs to  be considered when evaluating blood metabolite responses to 
supplemental Cr.
From Exp. 1, it was concluded that supplemental CrP did not affect 
gluconeogenesis. From Exp. 1 and 2, it was concluded that supplemental Cr did not affect 
glucose and insulin changes ova- time or glucose clearance rates in response to an IVGTT. 
However, interpretation o f the IVGTT data by the minimal model program (Exp. 2 only), 
showed that calves fed CrNIC were more insulin sensitive than control-fed calves and that 
BF-fed calves were less insulin sensitive that HF-fed calves. Further research needs to be 
conducted to determine if use of the minimal model approach would provide a better 
evaluation o f changes in insulin sensitivity in the neonatal calf.
Many unknown factors remain in Cr research. The need for Cr supplementation of 
practical livestock diets appears to depend on the Cr status o f the animal, the amount of 
bioavailable Cr in feedstuff's, and the exposure o f the animals to situations under which 
greater demands are placed on the animal. To date, few studies, especially in ruminants, 
have been conducted to compare different Cr sources and (or) levels supplemented.
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